b'<?xml version="1.0" encoding="utf-8"?>\n<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">\n<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">\n    \n    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />\n        <!-- AppResources meta begin -->\n        <script type="text/javascript">var ncbi_startTime = new Date();</script>\n        <!-- AppResources meta end -->\n        \n        <!-- TemplateResources meta begin -->\n        <meta name="paf_template" content="" />\n\n        <!-- TemplateResources meta end -->\n        \n        <!-- Logger begin -->\n        <meta name="ncbi_db" content="pmc" /><meta name="ncbi_pdid" content="article" /><meta name="ncbi_acc" content="" /><meta name="ncbi_domain" content="plosgen" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/articles/PMC2752168/" /><meta name="ncbi_app" content="pmc" />\n        <!-- Logger end -->\n        \n        <title>The Key Role of Genomics in Modern Vaccine and Drug Design for Emerging Infectious Diseases</title>\n        \n        <!-- AppResources external_resources begin -->\n        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>\n\n        <!-- AppResources external_resources end -->\n        \n        <!-- Page meta begin -->\n        <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2752168/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="citation_journal_title" content="PLoS Genetics" /><meta name="citation_title" content="The Key Role of Genomics in Modern Vaccine and Drug Design for Emerging Infectious Diseases" /><meta name="citation_authors" content="Kate L. Seib, Gordon Dougan, Rino Rappuoli" /><meta name="citation_date" content="October 2009" /><meta name="citation_issue" content="10" /><meta name="citation_volume" content="5" /><meta name="citation_doi" content="10.1371/journal.pgen.1000612" /><meta name="citation_abstract_html_url" content="/pmc/articles/PMC2752168/?report=abstract" /><meta name="citation_pmid" content="19855822" /><meta name="DC.Title" content="The Key Role of Genomics in Modern Vaccine and Drug Design for Emerging Infectious Diseases" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="Public Library of Science" /><meta name="DC.Contributor" content="Kate L. Seib" /><meta name="DC.Contributor" content="Gordon Dougan" /><meta name="DC.Contributor" content="Rino Rappuoli" /><meta name="DC.Date" content="2009 Oct" /><meta name="DC.Identifier" content="10.1371/journal.pgen.1000612" /><meta name="DC.Language" content="en" /><meta property="og:title" content="The Key Role of Genomics in Modern Vaccine and Drug Design for Emerging Infectious Diseases" /><meta property="og:type" content="article" /><meta property="og:description" content="It can be argued that the arrival of the \xe2\x80\x9cgenomics era\xe2\x80\x9d has significantly shifted the paradigm of vaccine and therapeutics development from microbiological to sequence-based approaches. Genome sequences provide a previously unattainable ..." /><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2752168/" /><meta property="og:site_name" content="PubMed Central (PMC)" /><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-logo-share.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbi" /><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc_extras_prnt.min.css" type="text/css" media="print" /><script type="text/javascript" src="/corehtml/pmc/js/common.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js">//</script><meta name="citationexporter" content="backend:\'https://api.ncbi.nlm.nih.gov/lit/ctxp/v1/pmc/\'" /><script type="text/javascript" src="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/jquery.citationexporter.min.js">//</script><link rel="stylesheet" href="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/citationexporter.css" type="text/css" /><script type="text/javascript">window.name="mainwindow";</script><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-plosgen.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style><style type="text/css">\n        div.pmc_para_cit li.highlight,\n        div.pmc_para_cit li.highlight .one_line_source\n        { background: #E0E0E0; }\n        a.bibr.highlight { background: #E0E0E0; } \n      </style><meta name="cited_in_systematic_reviews" content="" /><link rel="alternate" type="application/epub+zip" href="/pmc/articles/PMC2752168/epub/" /><link rel="alternate" type="application/pdf" href="/pmc/articles/PMC2752168/pdf/pgen.1000612.pdf" />\n\n        <!-- Page meta end -->\n    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="8A1BCFE9E9A46CB10000000001000100.m_8" />\n<meta name=\'referrer\' content=\'origin-when-cross-origin\'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4048120/3846471/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/3881636/3579733/4062871/12930/3964959/3855473/4047625/3854974/3854955/4076335/4128070/9685/3549676/3609192/3609193/3609213/3395586/4143404.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3411343/3882866/4157116.css" media="print" /></head>\n    <body class="article">\n        <div class="grid">\n            <div class="col twelve_col nomargin shadow">\n                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->\n                <div class="sysmessages">\n                    <noscript>\n\t<p class="nojs">\n\t<strong>Warning:</strong>\n\tThe NCBI web site requires JavaScript to function. \n\t<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>\n\t</p>\n\t</noscript>\n                </div>\n                <!--/.sysmessage-->\n                <div class="wrap">\n                    <div class="page">\n                        <div class="top">\n                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main\n                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to\n                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>\n                            <div class="header">\n    <div class="res_logo">\n  <h1 class="img_logo"><a href="/pmc/" class="pmc_logo offscreen">PMC</a></h1>\n  <div class="NLMLogo">\n    <a href="https://www.nlm.nih.gov/" title="US National Library of Medicine">US National Library of Medicine</a>\n    <br />\n    <a href="https://www.nih.gov/" title="National Institutes of Health">National Institutes of Health</a>\n  </div>\n</div>\n    <div class="search"><form method="get" action="/pmc/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="pmc" selected="selected" class="last" data-ac_dict="pmc-search-autocomplete">PMC</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search PMC. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:\'pmc-search-autocomplete\',disableUrl:\'NcbiSearchBarAutoComplCtrl\'" autocomplete="off" data-sbconfig="ds:\'no\',pjs:\'no\',afs:\'yes\'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>\n                        <a href="/pmc/advanced/">Advanced</a>\n                    </li><li>\n                        <a href="/pmc/journals/">Journal list</a>\n                    </li><li class="help">\n                        <a target="_blank" href="/books/NBK3825/">Help</a>\n                    </li></ul></div>\n</div>\n\n                            \n                            \n                        <!--<component id="Page" label="headcontent"/>-->\n                            \n                        </div>\n                        <div class="content">\n                            <!-- site messages -->\n                            <div class="container">\n    <div id="maincontent" class="content eight_col col">\n        <div class="navlink-box">\n            <ul class="page-breadcrumbs inline_list small"><li class="journal-list"><a href="/pmc/journals/" class="navlink">Journal List</a></li><li class="archive"><a class="navlink" href="/pmc/journals/331/">PLoS Genet</a></li><li class="issue-page"><a class="navlink" href="/pmc/issues/181622/">v.5(10); 2009 Oct</a></li><li class="accid">PMC2752168</li></ul>\n        </div>\n\n        <!-- Journal banner -->\n        <div class="pmc-page-banner whole_rhythm"><div><img src="/corehtml/pmc/pmcgifs/logo-plosgen.gif" alt="Logo of plosgen" usemap="#logo-imagemap" /><map id="logo-imagemap" name="logo-imagemap"><area shape="rect" coords="0,0,438,55" alt="PLoS Genetics" title="PLoS Genetics" href="http://www.plosgenetics.org/" ref="reftype=publisher&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext" /><area shape="rect" coords="106,56,202,74" alt="Submit to PLoS" title="Submit to PLoS" href="http://www.plosgenetics.org/static/checklist.action" ref="reftype=publisher&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext" /><area shape="rect" coords="204,56,302,74" alt="Get E-mail Alerts" title="Get E-mail Alerts" href="http://journals.plos.org/alerts" ref="reftype=publisher&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext" /><area shape="rect" coords="304,56,374,74" alt="Contact Us" title="Contact Us" href="http://www.plosgenetics.org/static/contact.action" ref="reftype=publisher&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext" /><area shape="rect" coords="440,0,500,55" alt="Public Library of Science (PLoS)" title="Public Library of Science (PLoS)" href="http://www.plos.org" ref="reftype=publisher&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext" /><area shape="rect" coords="0,56,104,74" alt="View this Article" title="View this Article" href="//dx.doi.org/10.1371/journal.pgen.1000612" ref="reftype=publisher&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CBanner&amp;TO=Content%20Provider%7CArticle%7CFullText" target="pmc_ext" /></map></div> </div>\n        \n        <!--component id=\'MainPortlet\' label=\'search-reference\'/-->\n        \n        <!-- Book content -->\n        <div class="">\n            \n        \n            \n            <div class="hide-overflow article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: [\'h2\'], headingExclude: \':hidden\'"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-citation half_rhythm no_top_margin clearfix"><div class="inline_block eight_col va_top"><div><div><span class="cit"><span id="pmcmata">PLoS Genet</span>. 2009 Oct; 5(10): e1000612. </span></div><div><span class="fm-vol-iss-date">Published online 2009 Oct 26. </span>  <span class="doi">doi:\xc2\xa0<a href="//dx.doi.org/10.1371%2Fjournal.pgen.1000612" target="pmc_ext" ref="reftype=other&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1371/journal.pgen.1000612</a></span></div></div></div><div class="inline_block four_col va_top show-overflow align_right"><div class="fm-citation-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC2752168</span></div><div class="fm-citation-pmid">PMID: <a href="/pubmed/19855822">19855822</a></div></div></div></div><h1 class="content-title">The Key Role of Genomics in Modern Vaccine and Drug Design for Emerging Infectious Diseases</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="/pubmed/?term=Seib%20KL%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19855822" class="affpopup" co-rid="_co_idm139696577787776" co-class="co-affbox">Kate L. Seib</a>,<sup>\n1\n</sup> <a href="/pubmed/?term=Dougan%20G%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19855822" class="affpopup" co-rid="_co_idm139696571770080" co-class="co-affbox">Gordon Dougan</a>,<sup>\n2\n</sup> and  <a href="/pubmed/?term=Rappuoli%20R%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19855822" class="affpopup" co-rid="_co_idm139696571673136" co-class="co-affbox">Rino Rappuoli</a><sup>\n1\n,</sup><sup>\n&#x0002a;\n</sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm139696577787776"><h3 class="no_margin">Kate L. Seib</h3><p><sup>1</sup>Novartis Vaccines and Diagnostics, Siena, Italy</p><div>Find articles by <a href="/pubmed/?term=Seib%20KL%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19855822">Kate L. Seib</a></div></div><div id="_co_idm139696571770080"><h3 class="no_margin">Gordon Dougan</h3><p><sup>2</sup>The Wellcome Trust Sanger Institute, The Wellcome Trust Genome Campus, Hinxton, Cambridge, United Kingdom</p><div>Find articles by <a href="/pubmed/?term=Dougan%20G%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19855822">Gordon Dougan</a></div></div><div id="_co_idm139696571673136"><h3 class="no_margin">Rino Rappuoli</h3><p><sup>1</sup>Novartis Vaccines and Diagnostics, Siena, Italy</p><div>Find articles by <a href="/pubmed/?term=Rappuoli%20R%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19855822">Rino Rappuoli</a></div></div></div></div><div class="contrib-group half_rhythm fm-editor">Nicholas J. Schork, <span class="fm-role">Editor</span><sup></sup></div><div class="fm-panel half_rhythm"><div class="togglers"><a href="#" class="pmctoggle" rid="idm139696612079424_ai idm139696577787904_ai idm139696576282960_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm139696612079424_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/">Disclaimer</a></div><div class="fm-authors-info fm-panel hide half_rhythm" id="idm139696612079424_ai" style="display:none"><div class="fm-affl" lang="en" id="aff1"><sup>1</sup>Novartis Vaccines and Diagnostics, Siena, Italy</div><div class="fm-affl" lang="en" id="aff2"><sup>2</sup>The Wellcome Trust Sanger Institute, The Wellcome Trust Genome Campus, Hinxton, Cambridge, United Kingdom</div><div class="fm-affl" lang="en" id="edit1">University of California San Diego and The Scripps Research Institute, United States of America</div><div id="cor1">&#x0002a; E-mail: <a href="mailto:dev@null" data-email="moc.sitravoN@ilouppaR.oniR" class="oemail">moc.sitravoN@ilouppaR.oniR</a></div></div><div class="fm-article-notes fm-panel half_rhythm"></div><div class="permissions fm-panel half_rhythm hide" id="idm139696612079424_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright</a> Seib et al.</div><div class="license half_rhythm">This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.</div></div></div><div id="pmclinksbox" class="links-box whole_rhythm"><div class="fm-panel"><div>This article has been <a href="/pmc/articles/PMC2752168/citedby/">cited by</a> other articles in PMC.</div></div></div></div><div class="sec"></div><div id="idm139696573368784" lang="en" class="tsec sec"><h2 class="head no_bottom_margin" id="idm139696573368784title">Abstract</h2><!--article-meta--><div><p id="__p1" class="p p-first-last">It can be argued that the arrival of the &#x0201c;genomics era&#x0201d; has significantly shifted the paradigm of vaccine and therapeutics development from microbiological to sequence-based approaches. Genome sequences provide a previously unattainable route to investigate the mechanisms that underpin pathogenesis. Genomics, transcriptomics, metabolomics, structural genomics, proteomics, and immunomics are being exploited to perfect the identification of targets, to design new vaccines and drugs, and to predict their effects in patients. Furthermore, human genomics and related studies are providing insights into aspects of host biology that are important in infectious disease. This ever-growing body of genomic data and new genome-based approaches will play a critical role in the future to enable timely development of vaccines and therapeutics to control emerging infectious diseases.</p></div></div><div id="idm139696573366752" class="tsec sec headless whole_rhythm"><p id="__p2" class="p p-first">By controlling debilitating and often-lethal infectious diseases, vaccines and antibiotics have had an enormous impact on world health. Now, with the arrival of the &#x0201c;genomics era,&#x0201d; a paradigm shift is occurring in the development of vaccines&#x02014;and potentially also in the development of antibiotics&#x02014;that is providing fresh impetus to this field. The world is still faced with a huge burden of infection, however, by classic pathogens (e.g., typhoid, measles), recently discovered causes of disease (e.g., <em>Helicobacter pylori</em> and hepatitis C virus [HCV]), and emerging infectious diseases (EIDs, e.g., H1N1 swine flu and severe acute respiratory syndrome coronavirus [SARS-CoV]). In addition, variant forms of previously identified infectious diseases are reemerging (e.g., <em>Streptococcus pyogenes</em>, also known as group A streptococcus [GAS], and dengue fever), along with antibiotic-resistant forms of microbes (e.g., methicillin-resistant <em>Staphylococcus aureus</em> [MRSA] and <em>Mycobacterium tuberculosis</em>) <a href="#pgen.1000612-Dong1" rid="pgen.1000612-Dong1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_569595697">[1]</a>,<a href="#pgen.1000612-Yang1" rid="pgen.1000612-Yang1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_569595694">[2]</a> (for a list of EIDs see <a href="http://www3.niaid.nih.gov/topics/emerging/list.htm" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">http://www3.niaid.nih.gov/topics/emerging/list.htm</a>). The World Health Organization (WHO) estimates that we can expect at least one such new pathogen to appear every year.</p><p id="__p3">The fact that an infectious disease has emerged or reemerged indicates immune na&#x000ef;vety in the infected population, or altered virulence potential or an increase in antibiotic/antiviral resistance in the pathogen population. The rapid development of vaccines and therapeutics that target these pathogens is therefore essential to limit their spread. Traditional empirical approaches that screen for vaccines or drugs a few candidates at a time are time-consuming and have often proven insufficient to control many EIDs, particularly when the causative pathogens are antigenically diverse (e.g., HIV), cannot be cultivated in the laboratory (e.g., HCV), lack suitable animal models of infection (e.g., <em>Neisseria</em> spp.), have complex mechanisms of pathogenesis (e.g., retroviruses), and/or are controlled by mucosal or T cell&#x02013;dependent immune responses rather than humoral immune responses (e.g., <em>Shigella</em> spp., <em>M. tuberculosis</em>) <a href="#pgen.1000612-Rappuoli1" rid="pgen.1000612-Rappuoli1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_569595760">[3]</a>. For many EIDs, the wealth of information emerging in the genome era has already had a significant impact on the way we approach vaccine and therapeutic development. For EIDs that appear in the near future, genomics will be in the first line of defense in terms of antigen identification, diagnostic development, and functional characterization.</p><p id="__p4">Since the completion of the genome sequence of <em>Haemophilus influenzae</em>&#x02014;the first finished bacterial genome sequence&#x02014;in 1995 <a href="#pgen.1000612-Fleischmann1" rid="pgen.1000612-Fleischmann1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_569595688">[4]</a>, advances in sequencing technology and bioinformatics have produced an exponential growth of genome sequence information. At least one genome sequence is now available for each major human pathogen. As of October 2009, over 1,000 bacterial genomes were &#x0201c;completed&#x0201d; (i.e., closed genomes and whole genome shotgun sequences) and more than 1,000 were ongoing; over 3,000 viral genomes were completed (<a href="http://www.genomesonline.org/gold.cgi" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">http://www.genomesonline.org/gold.cgi</a>, <a href="http://www.ncbi.nlm.nih.gov/genomes/MICROBES/microbial_taxtree.html" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">http://www.ncbi.nlm.nih.gov/genomes/MICROBES/microbial_taxtree.html</a>, <a href="http://cmr.jcvi.org/tigr-scripts/CMR/shared/Genomes.cgi" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">http://cmr.jcvi.org/tigr-scripts/CMR/shared/Genomes.cgi</a>). For a bacterial pathogen, which may have more than 4,000 genes, the genome sequence provides the complete genetic repertoire of antigens or drug targets from which novel candidates can be identified. For viral pathogens that may possess fewer than 10 genes, genomics can be used to define the variability that may exist between isolates. Host genetic factors also play a role in infectious disease <a href="#pgen.1000612-Casanova1" rid="pgen.1000612-Casanova1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_569595758">[5]</a>,<a href="#pgen.1000612-Burgner1" rid="pgen.1000612-Burgner1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_569595726">[6]</a>, however, and the availability of &#x0201c;complete&#x0201d; human genome sequences, as well as large-scale human genome projects (see <a href="http://www.1000genomes.org/" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">http://www.1000genomes.org/</a>), are valuable resources. Hence, the sequences of both pathogen and host genomes can facilitate identification of a growing number of potential vaccine and drug targets (<a href="/pmc/articles/PMC2752168/figure/pgen-1000612-g001/" target="figure" class="fig-table-link figpopup" rid-figpopup="pgen-1000612-g001" rid-ob="ob-pgen-1000612-g001" co-legend-rid="lgnd_pgen-1000612-g001"><span>Figure 1</span></a>). It is estimated that 10&#x02013;100 times more candidates can be identified in one to two years using genomics-based approaches than can be identified by conventional methods in the same time frame. Furthermore, genomics-based vaccine projects have substantially increased our understanding of microbial physiology, epidemiology, pathogenesis, and protein functions (see <a href="#pgen-1000612-box001" rid="pgen-1000612-box001" class=" boxed-text">Box 1</a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="pgen-1000612-g001" co-legend-rid="lgnd_pgen-1000612-g001"><a href="/pmc/articles/PMC2752168/figure/pgen-1000612-g001/" target="figure" rid-figpopup="pgen-1000612-g001" rid-ob="ob-pgen-1000612-g001"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139696577206368" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=2752168_pgen.1000612.g001.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is pgen.1000612.g001.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC2752168/bin/pgen.1000612.g001.jpg" /></a></div><div id="largeobj_idm139696577206368" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2752168/figure/pgen-1000612-g001/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_pgen-1000612-g001"><div><a class="figpopup" href="/pmc/articles/PMC2752168/figure/pgen-1000612-g001/" target="figure" rid-figpopup="pgen-1000612-g001" rid-ob="ob-pgen-1000612-g001">Figure 1</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Genomics-based approaches used in the control of EIDs from the outbreak of a disease to the development of a vaccine or drug.</strong><p id="__p5">(A) The causative agent of a disease may first be identified from patient samples by using metagenomics. (B) Vaccine and therapeutic targets can be identified from the pathogen genome using a variety of screening approaches that focus on the genome, transcriptome, proteome, immunome or structural genome. (C) The human genome can be screened to avoid homologies or similarities with pathogen vaccine and therapeutic targets, or to identify new targets. (D) Once candidate vaccine and therapeutic targets have been identified they must be shown to provide protection against disease and to be safe for use in patients. (E) The clinically tested vaccine or therapeutic can then be licensed for use. The clinical responses of a vaccine and/or therapeutic can be analyzed using human genome based studies (dotted arrows). The pathogen genome can also be used to analyze mutants that are able to evade the immune system in vaccinated subjects or organisms that develop antibiotic resistance. Examples of the approaches indicated are given in <a href="/pmc/articles/PMC2752168/table/pgen-1000612-t001/" target="table" class="fig-table-link figpopup" rid-figpopup="pgen-1000612-t001" rid-ob="ob-pgen-1000612-t001" co-legend-rid=""><span>Table 1</span></a>.</p></div></div></div><div class="boxed-text-box whole_rhythm hide-overflow" id="pgen-1000612-box001"><div class="sec" id="s1a1"><h3 id="s1a1title">Box 1: Reverse Vaccinology Drives the Discovery of New Protein Functions</h3><p id="__p6" class="p p-first">Reverse vaccinology involves the in silico screening of the entire genome of a pathogen to find genes that encode proteins with the attributes of good vaccine targets, using either the genome of a single pathogenic isolate or the pan-genome (the genomic information from several isolates) of a pathogenic species.</p><div class="sec" id="s1a1a"><h4 id="s1a1atitle">Pili in pathogenic streptococci play a key role in virulence and are promising vaccine candidates</h4><p id="__p7" class="p p-first">The identification of pili (long filamentous structures that extend from the bacterial surface) in the main pathogenic strains of streptococci is a good example of how genomics can lead to the discovery of protein functions and increased understanding of host&#x02013;pathogen interactions. The pili of gram-negative bacteria are well-described virulence factors. Little was known, however, about pili in gram-positive bacteria before the sequencing and analysis of the genomes of <em>S. pyogenes</em>, <em>S. agalactiae</em>, and <em>S. pneumoniae</em> (reviewed in <a href="#pgen.1000612-Telford1" rid="pgen.1000612-Telford1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_569595716">[72]</a>).</p><p id="__p8">During analysis of eight <em>S. agalactiae</em> genome sequences, three protective antigens identified by pan-genomic reverse vaccinology <a href="#pgen.1000612-Maione1" rid="pgen.1000612-Maione1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_569595757">[20]</a> were found to contain LPXTG motifs typical of cell wall-anchored proteins and seen to assemble into pili <a href="#pgen.1000612-Lauer1" rid="pgen.1000612-Lauer1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_569595699">[73]</a>. Further bioinformatics analysis revealed three independent loci that encode structurally distinct pilus types, each of which contains two surface-exposed antigens capable of eliciting protective immunity in mice <a href="#pgen.1000612-Mora1" rid="pgen.1000612-Mora1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_569595717">[75]</a>. Because of the limited variability of <em>S. agalactiae</em> pili, it has been suggested that a combination of only three pilin subunits could lead to broad protective immunity <a href="#pgen.1000612-Margarit1" rid="pgen.1000612-Margarit1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_569595693">[74]</a>.</p><p id="__p9">Following the identification of <em>S. agalactiae</em> pili, typical pilus regions were identified in the available <em>S. pyogenes</em> genomes based on the presence of genes encoding LPXTG-containing proteins. In addition, a combination of recombinant pilus proteins was shown to confer protection in mice against mucosal challenge with virulent <em>S. pyogenes</em> isolates <a href="#pgen.1000612-Mora1" rid="pgen.1000612-Mora1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_569595740">[75]</a>. Falugi and colleagues have since found that <em>S. pyogenes</em> pili are encoded by nine different gene clusters, and they estimate that a vaccine comprising a combination of 12 backbone variants could provide protection against over 90&#x00025; of circulating <em>S. pyogenes</em> strains <a href="#pgen.1000612-Falugi1" rid="pgen.1000612-Falugi1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_569595707">[76]</a>.</p><p id="__p10" class="p p-last">The availability of multiple complete genome sequences for <em>S. pneumoniae</em>, and the increased understanding of pilus proteins in other pathogenic streptococci, led to the discovery of two pilus &#x0201c;islands&#x0201d; that encode proteins that play a role in adherence to lung epithelial cells and colonization in a murine model of infection, where they elicit host inflammatory responses <a href="#pgen.1000612-Barocchi1" rid="pgen.1000612-Barocchi1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_569595774">[77]</a>,<a href="#pgen.1000612-Bagnoli1" rid="pgen.1000612-Bagnoli1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_569595759">[78]</a>. In addition, the pilus subunits confer protection in passive and active immunization models <a href="#pgen.1000612-Gianfaldoni1" rid="pgen.1000612-Gianfaldoni1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_569595749">[79]</a>. The presence of pili that contain protective antigens in all three principal streptococcal pathogens indicates that these structures play an important role in virulence.</p></div><div class="sec" id="s1a1b"><h4 id="s1a1btitle">Reverse vaccinology leads to identification of the fHBP and its role in meningococcal species specificity</h4><p id="__p11" class="p p-first-last">Serogroup B <em>N. meningitidis</em> (MenB) strains are responsible for the majority of meningococcal disease in the developed world, yet there is no comprehensive MenB vaccine available. Screening of the MenB genome for vaccine candidates by using reverse vaccinology led to the discovery of the meningococcal factor H-binding protein (fHBP) <a href="#pgen.1000612-Pizza1" rid="pgen.1000612-Pizza1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_569595743">[15]</a>, which was recently suggested to play an important role in the species specificity of <em>N. meningitidis</em>\n<a href="#pgen.1000612-Granoff1" rid="pgen.1000612-Granoff1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_569595766">[80]</a>. fHBP is a component of the Novartis multivalent MenB vaccine that entered Phase III clinical testing in 2008 <a href="#pgen.1000612-Giuliani1" rid="pgen.1000612-Giuliani1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_569595777">[16]</a>,<a href="#pgen.1000612-Rappuoli2" rid="pgen.1000612-Rappuoli2" class=" bibr popnode">[17]</a> and is also under investigation by Wyeth Vaccines (designated LP2086) <a href="#pgen.1000612-McNeil1" rid="pgen.1000612-McNeil1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_569595739">[81]</a> and other groups <a href="#pgen.1000612-Koeberling1" rid="pgen.1000612-Koeberling1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_569595701">[82]</a>. Initially identified as the genome-derived <em>Neisseria</em> antigen 1870 (GNA1870), a <em>Neisseria</em>-specific putative surface lipoprotein of unknown function, fHBP was renamed because of its ability to bind complement factor H (fH), a molecule that down-regulates activation of the complement alternative pathway. Hence, binding of fH to the surface of <em>Neisseria</em> allows the pathogen to evade complement-mediated killing by the innate immune system <a href="#pgen.1000612-Madico1" rid="pgen.1000612-Madico1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_569595762">[83]</a>. fHBP is expressed by all <em>N. meningitidis</em> strains studied <a href="#pgen.1000612-Masignani2" rid="pgen.1000612-Masignani2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_569595730">[84]</a>. It induces high levels of bactericidal antibodies in mice <a href="#pgen.1000612-Giuliani1" rid="pgen.1000612-Giuliani1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_569595761">[16]</a> and is important for survival of bacteria in human serum and blood <a href="#pgen.1000612-Madico1" rid="pgen.1000612-Madico1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_569595733">[83]</a>,<a href="#pgen.1000612-Welsch1" rid="pgen.1000612-Welsch1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_569595753">[85]</a>,<a href="#pgen.1000612-Seib1" rid="pgen.1000612-Seib1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_569595741">[86]</a>. The discovery that binding of fH to <em>N. meningitidis</em> is specific for human fH, and that human fH alone is able to down-regulate complement activation and bactericidal activity leading to increased bacterial survival has significant implications for the study of this organism <a href="#pgen.1000612-Granoff1" rid="pgen.1000612-Granoff1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_569595742">[80]</a>. The administration of human fH to infant rats challenged with MenB led to a greater than 10-fold increase in survival of bacteria <a href="#pgen.1000612-Granoff1" rid="pgen.1000612-Granoff1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_569595711">[80]</a>, providing an important insight into host&#x02013;pathogen interactions that may lead to the development of new animal models of infection.</p></div></div></div><p id="__p12" class="p">From the outbreak of a disease, metagenomics (the study of all the genetic material recovered directly from a sample) can be applied to diseased human samples to aid the rapid identification of the causative agent <a href="#pgen.1000612-Nakamura1" rid="pgen.1000612-Nakamura1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_569595690">[7]</a>,<a href="#pgen.1000612-Bittar1" rid="pgen.1000612-Bittar1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_569595692">[8]</a>. Once the complete genome sequence of the organism is available, high-throughput approaches can be used to screen for target molecules, as outlined below and in <a href="/pmc/articles/PMC2752168/table/pgen-1000612-t001/" target="table" class="fig-table-link figpopup" rid-figpopup="pgen-1000612-t001" rid-ob="ob-pgen-1000612-t001" co-legend-rid=""><span>Table 1</span></a>\n<a href="#pgen.1000612-Rinaudo1" rid="pgen.1000612-Rinaudo1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_569595771">[9]</a>,<a href="#pgen.1000612-Kaushik1" rid="pgen.1000612-Kaushik1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_569595750">[10]</a>. Screening approaches vary depending on the nature of the pathogen but are based on several accepted principles and key requirements of vaccines and therapeutics, including the need for targets to be (i) expressed and accessible to the host immune system, or to a therapeutic agent, during human disease; (ii) genetically conserved; (iii) important for survival or pathogenesis; and (iv) free of measurable homology or similarity to host factors. Although many of the approaches described here focus on vaccine development, which involves screening of candidates for immunogenicity, they are largely applicable to drug development by altering the selection criteria used and screening candidates against compound libraries <a href="#pgen.1000612-Pucci1" rid="pgen.1000612-Pucci1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_569595775">[11]</a>&#x02013;<a href="#pgen.1000612-VanVoorhis1" rid="pgen.1000612-VanVoorhis1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_585244562">[13]</a>.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="pgen-1000612-t001"><h3>Table 1</h3><!--caption a7--><div class="caption"><!--caption a8--><strong>Approaches to identify vaccine and/or drug targets against EIDs in the genomic era.</strong></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139696647642704" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><td align="left" rowspan="1" colspan="1">Approach</td><td align="left" rowspan="1" colspan="1">Methods Used</td><td align="left" rowspan="1" colspan="1">Limitations of Method</td><td align="left" rowspan="1" colspan="1">Example</td></tr><tr><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">Organism</td><td align="left" rowspan="1" colspan="1">Disease</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">\n<strong>Genomics/reverse vaccinology:</strong> Analysis of the genetic material of an organism in order to identify the repertoire of protein antigens/drug targets the organism has the potential to express.</td><td align="left" rowspan="1" colspan="1">Bioinformatics screening of the genome sequence to identify ORFs predicted to be exposed on the surface of the pathogen or secreted, expression of recombinant proteins, generation of antibodies in mice to confirm surface exposure, and bactericidal activity <a href="#pgen.1000612-Masignani1" rid="pgen.1000612-Masignani1" class=" bibr popnode">[14]</a>.</td><td align="left" rowspan="1" colspan="1">Prediction algorithms need to be validated. Non-protein antigens including polysaccharides or glycolipids, and post-translational modifications cannot be identified. High-throughput cloning and protein expression is required.</td><td align="left" rowspan="1" colspan="1">Serogroup B <em>N. meningitidis</em>\n<a href="#pgen.1000612-Pizza1" rid="pgen.1000612-Pizza1" class=" bibr popnode">[15]</a>,<a href="#pgen.1000612-Giuliani1" rid="pgen.1000612-Giuliani1" class=" bibr popnode">[16]</a>\n</td><td align="left" rowspan="1" colspan="1">Major cause of septicemia and meningitis in the developed world.</td></tr><tr><td align="left" rowspan="1" colspan="1">\n<strong>Pan-genomics:</strong> Analysis of the genetic material of several organisms of a single species to identify conserved antigens/targets and ensure the chosen target covers the diversity of the organism.</td><td align="left" rowspan="1" colspan="1">Similar to above, but ORFs are chosen by screening of multiple genomes with either direct sequencing or comparative genome hybridization <a href="#pgen.1000612-Muzzi1" rid="pgen.1000612-Muzzi1" class=" bibr popnode">[18]</a>.</td><td align="left" rowspan="1" colspan="1">Sequences of multiple isolates of a species are required. Similar limitations as described above.</td><td align="left" rowspan="1" colspan="1">\n<em>S. agalactiae</em>\n<a href="#pgen.1000612-Maione1" rid="pgen.1000612-Maione1" class=" bibr popnode">[20]</a>\n</td><td align="left" rowspan="1" colspan="1">Leading cause of neonatal bacterial sepsis, pneumonia, and meningitis in the US and Europe.</td></tr><tr><td align="left" rowspan="1" colspan="1">\n<strong>Comparative genomics:</strong> Analysis of the genetic material of several individuals of a single species, to identify antigens/targets that are present in pathogenic strains but absent in commensal strains, and thus important for disease.</td><td align="left" rowspan="1" colspan="1">Similar to pangenomics, but ORFs are chosen by screening of genomes from multiple strains of pathogenic and commensal strains of a species <a href="#pgen.1000612-Muzzi1" rid="pgen.1000612-Muzzi1" class=" bibr popnode">[18]</a>,<a href="#pgen.1000612-Bhagwat1" rid="pgen.1000612-Bhagwat1" class=" bibr popnode">[21]</a>.</td><td align="left" rowspan="1" colspan="1">Similar limitations as for the above two approaches.</td><td align="left" rowspan="1" colspan="1">\n<em>E. coli</em>\n<a href="#pgen.1000612-Rasko1" rid="pgen.1000612-Rasko1" class=" bibr popnode">[22]</a>\n</td><td align="left" rowspan="1" colspan="1">Major cause of mild to severe diarrhea, hemolytic-uremic syndrome, and urinary tract infections.</td></tr><tr><td align="left" rowspan="1" colspan="1">\n<strong>Transcriptomics:</strong> Analysis of the set of RNA transcripts expressed by an organism under a specified condition.</td><td align="left" rowspan="1" colspan="1">Gene expression is evaluated in vitro or in vivo using DNA microarrays or cDNA sequencing <a href="#pgen.1000612-Dhiman1" rid="pgen.1000612-Dhiman1" class=" bibr popnode">[24]</a>.</td><td align="left" rowspan="1" colspan="1">There is no direct correlation between the levels of mRNA and protein. In vivo studies require relatively large amounts of mRNA.</td><td align="left" rowspan="1" colspan="1">\n<em>V. cholerae</em>\n<a href="#pgen.1000612-Merrell1" rid="pgen.1000612-Merrell1" class=" bibr popnode">[26]</a>\n</td><td align="left" rowspan="1" colspan="1">Causes diseases ranging from self-limiting to severe, life-threatening diarrhea, wound infections, and sepsis.</td></tr><tr><td align="left" rowspan="1" colspan="1">\n<strong>Functional genomics:</strong> Analysis of the role of genes and proteins in order to identify genes required for survival under specific conditions.</td><td align="left" rowspan="1" colspan="1">Genes that are functionally essential in specific conditions in vitro or in vivo are determined by gene inhibition followed by screening of mutants in animal models or cell culture to identify attenuated clones <a href="#pgen.1000612-Mazurkiewicz1" rid="pgen.1000612-Mazurkiewicz1" class=" bibr popnode">[87]</a>.</td><td align="left" rowspan="1" colspan="1">Genetic tools, acceptance of transposons, and natural competence of the pathogen are required.</td><td align="left" rowspan="1" colspan="1">\n<em>H. pylori</em>\n<a href="#pgen.1000612-Kavermann1" rid="pgen.1000612-Kavermann1" class=" bibr popnode">[32]</a>\n</td><td align="left" rowspan="1" colspan="1">Major cause of duodenal and gastric ulcers and stomach cancer as a result of chronic low-level inflammation of the stomach lining.</td></tr><tr><td align="left" rowspan="1" colspan="1">\n<strong>Proteomics:</strong> Analysis of the set of proteins expressed by an organism under a specified condition and/or in specific cellular locations (e.g., on the cell surface).</td><td align="left" rowspan="1" colspan="1">2D-PAGE, MS, and chromatographic techniques to identify proteins from whole cells, fractionated samples, or the cell surface <a href="#pgen.1000612-Zhu1" rid="pgen.1000612-Zhu1" class=" bibr popnode">[34]</a>.</td><td align="left" rowspan="1" colspan="1">Proteins with low abundance and/or solubility and proteins that are only expressed in vivo may not be identified.</td><td align="left" rowspan="1" colspan="1">\n<em>S. pyogenes</em>\n<a href="#pgen.1000612-RodriguezOrtega1" rid="pgen.1000612-RodriguezOrtega1" class=" bibr popnode">[36]</a>\n</td><td align="left" rowspan="1" colspan="1">Cause of a range of diseases from mild pharyngitis to severe toxic shock syndrome, necrotizing fasciitis, and rheumatic fever.</td></tr><tr><td align="left" rowspan="1" colspan="1">\n<strong>Immunomics:</strong> Analysis of the subset of proteins/epitopes that interact with the host immune system.</td><td align="left" rowspan="1" colspan="1">Analysis of seroreactive proteins, using 2D-PAGE, phage display libraries, or protein microarrays, probed with host sera <a href="#pgen.1000612-Meinke1" rid="pgen.1000612-Meinke1" class=" bibr popnode">[38]</a>. Bioinformatics prediction of B cell and T cell epitopes <a href="#pgen.1000612-DeGroot1" rid="pgen.1000612-DeGroot1" class=" bibr popnode">[37]</a>.</td><td align="left" rowspan="1" colspan="1">Potential bias against sequences that cannot be displayed. Large conformational epitopes made up of noncontiguous amino acids may not be detected. Prediction of B cell epitopes is difficult due to the need to identify conformational epitopes.</td><td align="left" rowspan="1" colspan="1">\n<em>S. aureus</em>\n<a href="#pgen.1000612-Vytvytska1" rid="pgen.1000612-Vytvytska1" class=" bibr popnode">[39]</a>\n</td><td align="left" rowspan="1" colspan="1">Cause of wound infections. Has emerged as a significant opportunistic pathogen due to antibiotic resistance.</td></tr><tr><td align="left" rowspan="1" colspan="1">\n<strong>Structural genomics:</strong> Analysis of the three-dimensional structure of an organism\'s proteins and how they interact with antibodies or therapeutics.</td><td align="left" rowspan="1" colspan="1">NMR or crystallography to determine the structure of proteins in the presence/absence of antibodies or therapeutics <a href="#pgen.1000612-Dormitzer1" rid="pgen.1000612-Dormitzer1" class=" bibr popnode">[51]</a>.</td><td align="left" rowspan="1" colspan="1">Poor understanding of determinants of immunogenicity, immunodominance, and structure-function relationships.</td><td align="left" rowspan="1" colspan="1">HIV <a href="#pgen.1000612-Zhou1" rid="pgen.1000612-Zhou1" class=" bibr popnode">[53]</a>\n</td><td align="left" rowspan="1" colspan="1">Causative agent of AIDS.</td></tr><tr><td align="left" rowspan="1" colspan="1">\n<strong>Vaccinomics/immunogenetics pharmacogenetics:</strong> Analysis of how the human immune system responds to a vaccine or drug.</td><td align="left" rowspan="1" colspan="1">Investigation of genetic heterogeneity/polymorphisms in the host, at the individual or population level, that may alter immune responses to vaccines <a href="#pgen.1000612-Poland1" rid="pgen.1000612-Poland1" class=" bibr popnode">[68]</a> or metabolism of therapeutics <a href="#pgen.1000612-Baudhuin1" rid="pgen.1000612-Baudhuin1" class=" bibr popnode">[71]</a>.</td><td align="left" rowspan="1" colspan="1">Ethical issues of &#x0201c;personalized&#x0201d; medicine. Immense diversity of the human genome and, in particular, in the human immune response.</td><td align="left" rowspan="1" colspan="1">Mumps virus <a href="#pgen.1000612-Ovsyannikova1" rid="pgen.1000612-Ovsyannikova1" class=" bibr popnode">[69]</a>\n</td><td align="left" rowspan="1" colspan="1">Cause of disease ranging from self-limiting parotid inflammation to epididymo-orchitis, meningitis, and encephalitis.</td></tr></tbody></table></div><div id="largeobj_idm139696647642704" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2752168/table/pgen-1000612-t001/?report=objectonly">Open in a separate window</a></div></div></div><div id="s2" class="tsec sec"><h2 class="head no_bottom_margin" id="s2title">Reverse Vaccinology, Pan-genomics, and Comparative Genomics</h2><p id="__p13" class="p p-first">The idea behind reverse vaccinology is to screen an entire pathogen genome to find genes that encode proteins with the attributes of good vaccine targets, such as, for example, bacterial surface associated proteins <a href="#pgen.1000612-Masignani1" rid="pgen.1000612-Masignani1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_569595764">[14]</a>. These proteins can then undergo normal laboratory evaluation for immunogenicity. The <em>Neisseria meningitidis</em> serogroup B (MenB) reverse vaccinology project provides the &#x0201c;proof of concept&#x0201d; for this type of approach. This project identified more novel vaccine candidates in 18 months than had been discovered in 40 years of conventional vaccinology <a href="#pgen.1000612-Pizza1" rid="pgen.1000612-Pizza1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_569595715">[15]</a>. Analysis of the genome sequence of the virulent MenB strain MC58 found 2,158 predicted open reading frames (ORFs); these were screened using bioinformatics tools to identify 570 ORFs that were predicted to encode surface-exposed or secreted proteins that might be accessible to the immune system <a href="#pgen.1000612-Pizza1" rid="pgen.1000612-Pizza1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_569595708">[15]</a>. Antigen screening continued on the basis of several criteria: the ability of antigens to be expressed in <em>Escherichia coli</em> as recombinant proteins (350 candidates); confirmation by ELISA and flow cytometry that the antigen is exposed on the cell surface (91 candidates); the ability of induced antibodies to elicit killing, as measured by serum bactericidal assay and/or passive protection in infant rat assays (28 candidates); and screening of a panel of diverse meningococcal isolates to determine whether the antigens are conserved. This approach resulted in the development of a multi-component recombinant MenB vaccine that entered Phase III clinical trials in 2008 <a href="#pgen.1000612-Giuliani1" rid="pgen.1000612-Giuliani1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_569595776">[16]</a>,<a href="#pgen.1000612-Rappuoli2" rid="pgen.1000612-Rappuoli2" class=" bibr popnode">[17]</a>.</p><p id="__p14">As multiple genome sequences become available for a single species, the concept of pan-genomic reverse vaccinology is emerging as a powerful tool to identify vaccine candidates in antigenically diverse species <a href="#pgen.1000612-Muzzi1" rid="pgen.1000612-Muzzi1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_569595721">[18]</a>. Pan-genomics aims to identify the full complement of genes in a species, based on the superset of genes in several strains of the same species. Analysis of the genome sequences of eight <em>Streptococcus agalactiae</em> (also known as group B streptococcus) strains revealed substantial genetic heterogeneity and the extended gene repertoire of the species <a href="#pgen.1000612-Tettelin1" rid="pgen.1000612-Tettelin1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_569595752">[19]</a>. Screening found a total of 589 genes predicted to encode surface-exposed or secreted proteins in the <em>S. agalactiae</em> pan-genome (396 from the &#x0201c;core genome&#x0201d;&#x02014;genes conserved in all strains&#x02014;and 193 from the &#x0201c;dispensable genome&#x0201d;&#x02014;genes that are present in two or more strains and are hence considered dispensable for survival). Based on further screening of this pool of candidates, including the ability of recombinant proteins to provide protection when used to immunize animals, a combination of four antigens&#x02014;only one of which is in the core genome&#x02014;was selected and shown to confer protection against a panel of <em>S. agalactiae</em> strains <a href="#pgen.1000612-Maione1" rid="pgen.1000612-Maione1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_569595687">[20]</a>.</p><p id="__p15">Whereas genome sequencing projects have typically focused on pathogenic organisms, comparison of the genomes of pathogenic and nonpathogenic strains allows vaccine and drug targets to be identified on the basis of proteins that are specifically involved in pathogenesis <a href="#pgen.1000612-Bhagwat1" rid="pgen.1000612-Bhagwat1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_569595748">[21]</a>. Comparative studies of up to 17 commensal and pathogenic <em>E. coli</em> genomes identified genes unique to certain pathogenic strains that are largely absent in commensal strains. This filter decreases the pool of targets to be screened and potentially limits any detrimental effects of therapeutics on the composition of the commensal flora <a href="#pgen.1000612-Rasko1" rid="pgen.1000612-Rasko1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_569595702">[22]</a>.</p><p id="__p16" class="p p-last">New sequencing technologies will also open up opportunities for monitoring pathogen vaccine escape by screening for evidence of immune selection in the genomes of pathogen populations before and after vaccine selection. By deep-sequencing of bacterial and viral populations it will be possible to identify antigens under immune selection by monitoring the clustering of single nucleotide polymorphisms (SNPs) and other mutations that affect protein sequence. This approach has already been used to search for evidence of antigenic variation/selection in populations of <em>Salmonella enterica</em> serovar Typhi <a href="#pgen.1000612-Holt1" rid="pgen.1000612-Holt1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_569595718">[23]</a>, where variation is extremely limited. Similar sequencing strategies could be applied to populations of bacteria taken before or after a vaccine trial in a particular geographical region.</p></div><div id="s3" class="tsec sec"><h2 class="head no_bottom_margin" id="s3title">Beyond Genomics: Other -Omics Approaches to Study Pathogens</h2><p id="__p17" class="p p-first">Pathogen genes that are up-regulated during infection and/or essential for microorganism survival or pathogenesis can be identified by using transcriptomics, i.e., the analysis of a near complete set of RNA transcripts expressed by the pathogen under a specified condition. Comprehensive DNA-based microarray chips (probed with cDNA generated from RNA by reverse transcription) <a href="#pgen.1000612-Dhiman1" rid="pgen.1000612-Dhiman1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_569595778">[24]</a> and ultra-high-throughput sequencing technologies that allow rapid sequencing and direct quantification of cDNA <a href="#pgen.1000612-Morozova1" rid="pgen.1000612-Morozova1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_569595729">[25]</a> enable the transcriptome of a pathogen to be characterized and particular types of gene product to be identified. For example, genes involved in the hyperinfectious state of <em>Vibrio cholerae</em>, which appears after passage through the human gastrointestinal tract, were identified through a comparison of the transcriptome of bacteria isolated directly from stool samples of cholera patients with that of <em>V. cholerae</em> grown in vitro <a href="#pgen.1000612-Merrell1" rid="pgen.1000612-Merrell1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_569595732">[26]</a>. Similarly, analysis of the transcription profile of <em>M. tuberculosis</em> during early infection in immune-competent (BALB/c) and severe combined immunodeficient (SCID) mice revealed a set of 67 genes activated exclusively in response to the host immune system <a href="#pgen.1000612-Talaat1" rid="pgen.1000612-Talaat1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_569595710">[27]</a>.</p><p id="__p18">Functional genomics&#x02014;linking genotype, through transcriptomics and proteomics, to phenotype&#x02014;has been applied to many pathogens to identify genes essential to survival or virulence that may be valid vaccine candidates. DNA microarrays can be used to screen comprehensive libraries of pathogen mutants, by comparing bacterial isolates from before and after passage through animal models or exposure to compound libraries to identify attenuated clones <a href="#pgen.1000612-Scarselli1" rid="pgen.1000612-Scarselli1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_569595722">[28]</a>&#x02013;<a href="#pgen.1000612-Sakata1" rid="pgen.1000612-Sakata1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_569595744">[30]</a>. For example, these methods have been used to identify 65 novel MenB genes that are required for the pathogen to cause septicemia in infant rats <a href="#pgen.1000612-Sun1" rid="pgen.1000612-Sun1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_569595770">[31]</a>, 47 genes essential for <em>H. pylori</em> gastric colonization of the gerbil <a href="#pgen.1000612-Kavermann1" rid="pgen.1000612-Kavermann1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_569595751">[32]</a>, and genes contributing to <em>M. tuberculosis</em> persistence in the host <a href="#pgen.1000612-Sassetti1" rid="pgen.1000612-Sassetti1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_569595772">[33]</a>.</p><p id="__p19">Analysis of a pathogen\'s proteome (the near complete set of proteins expressed under a specified condition) to reveal potential vaccine and drug candidates can add significant value to in silico approaches <a href="#pgen.1000612-Zhu1" rid="pgen.1000612-Zhu1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_569595720">[34]</a>. High-throughput proteomic analyses can be performed by using mass spectrometry (MS), chromatographic techniques, and protein microarrays <a href="#pgen.1000612-Grandi1" rid="pgen.1000612-Grandi1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_569595738">[35]</a>. A novel proteome-based approach has been applied to identify the surface proteins of GAS by making use of proteolytic enzymes to &#x0201c;shave&#x0201d; the bacterial surface, releasing exposed proteins and partially exposed peptides. Seventeen surface proteins of a virulent GAS strain were identified in this way by using MS and genome sequence analysis. Their location on the pathogen surface was confirmed by flow cytometry, and one of them provided protective immunity in a mouse model of the disease <a href="#pgen.1000612-RodriguezOrtega1" rid="pgen.1000612-RodriguezOrtega1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_569595763">[36]</a>.</p><p id="__p20">The proteome of a pathogen can also be screened to identify the immunome (the near complete set of pathogen proteins or epitopes that interact with the host immune system) using in vitro or in silico techniques <a href="#pgen.1000612-DeGroot1" rid="pgen.1000612-DeGroot1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_569595689">[37]</a>,<a href="#pgen.1000612-Meinke1" rid="pgen.1000612-Meinke1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_569595706">[38]</a>. In vitro identification and screening of the immunome are based on the idea that antibodies present in serum from a host, which has been exposed to a pathogen, represent a molecular &#x0201c;imprint&#x0201d; of the pathogen\'s immunogenic proteins and can be used to identify vaccine candidates. As such, several techniques have been developed to allow the high-throughput display of pathogen proteins, and the subsequent screening for proteins that interact with antibodies in sera. Immunogenic surface proteins of several organisms have been identified, including <em>S. aureus</em> using 2D-PAGE, membrane blotting, and MS <a href="#pgen.1000612-Vytvytska1" rid="pgen.1000612-Vytvytska1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_569595725">[39]</a>; <em>S. agalactiae</em>, <em>S. pyogenes</em>, and <em>Streptococcus pneumoniae</em> using phage- or <em>E. coli</em>-based comprehensive genomic peptide expression libraries <a href="#pgen.1000612-Meinke1" rid="pgen.1000612-Meinke1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_569595698">[38]</a>,<a href="#pgen.1000612-Giefing1" rid="pgen.1000612-Giefing1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_569595768">[40]</a>; and <em>Francisella tularensis</em> (the causative agent of tularemia or rabbit fever) <a href="#pgen.1000612-Eyles1" rid="pgen.1000612-Eyles1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_569595728">[41]</a> and <em>V. cholerae</em> using protein microarray chips <a href="#pgen.1000612-Rolfs1" rid="pgen.1000612-Rolfs1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_569595709">[42]</a>. Protein microarrays, in which proteins from the pathogen are spotted onto a microarray chip, can also be used to characterize protein&#x02013;drug interactions, as well as other protein&#x02013;protein, protein&#x02013;nucleic acid, ligand&#x02013;receptor, and enzyme&#x02013;substrate interactions <a href="#pgen.1000612-Stoevesandt1" rid="pgen.1000612-Stoevesandt1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_848031067">[43]</a>.</p><p id="__p21">The ability to predict in silico which pathogen epitopes will be recognized by B cells or T cells has greatly improved in recent years <a href="#pgen.1000612-DeGroot2" rid="pgen.1000612-DeGroot2" class=" bibr popnode">[44]</a>. Large-scale screening of pathogens including HIV, <em>Bacillus anthracis</em>, <em>M. tuberculosis</em>, <em>F. tularensis</em>, <em>Yersinia pestis</em> (the causative agent of bubonic plague), flaviviruses, and influenza for B cell and T cell epitopes is currently underway <a href="#pgen.1000612-Sette1" rid="pgen.1000612-Sette1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_569595696">[45]</a>,<a href="#pgen.1000612-DeGroot3" rid="pgen.1000612-DeGroot3" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_569595691">[46]</a>. Although epitope prediction is not foolproof, it can serve as a guide for further biological evaluation. T cell epitopes are presented by MHC/HLA proteins on the surface of antigen-presenting cells, which vary considerably between hosts, complicating the task of functional epitope prediction. Additionally, B cell epitopes can be both linear and conformational. The ultimate aim of researchers in this field of study would be to engineer a single peptide that represents defined epitope combinations from a protein or organism, enabling the genetic variability of both pathogen and host to be overcome <a href="#pgen.1000612-DeGroot2" rid="pgen.1000612-DeGroot2" class=" bibr popnode">[44]</a>.</p><p id="__p22" class="p p-last">Structural genomics&#x02014;the study of the three-dimensional structures of the proteins produced by a species&#x02014;is increasingly being applied to vaccine and drug development as a result of the explosion of genome and proteome data, and continuing improvements in the fields of protein expression, purification, and structural determination <a href="#pgen.1000612-Lundstrom1" rid="pgen.1000612-Lundstrom1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_569595700">[47]</a>. The structure-based design of antiviral therapeutics has led to the development of drugs directed at the active sites of the HIV-1 protease <a href="#pgen.1000612-Kaldor1" rid="pgen.1000612-Kaldor1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_569595769">[48]</a> and influenza neuraminidase <a href="#pgen.1000612-Kim1" rid="pgen.1000612-Kim1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_569595714">[49]</a>. More than 45,000 high-resolution protein structures are available in public databases (see <a href="http://www.wwpdb.org/stats.html" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">http://www.wwpdb.org/stats.html</a>), and several initiatives have been established to pursue high-throughput characterization of protein structures on a genome-wide scale <a href="#pgen.1000612-Todd1" rid="pgen.1000612-Todd1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_569595703">[50]</a>, focusing on determining and understanding the structural basis of immune-dominant and immune-recessive antigens as well as protein active sites and potential drug-binding sites <a href="#pgen.1000612-Dormitzer1" rid="pgen.1000612-Dormitzer1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_848031071">[51]</a>,<a href="#pgen.1000612-Nicola1" rid="pgen.1000612-Nicola1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_585244561">[52]</a>. For example, structural characterization of the HIV envelope proteins gp120 and gp41 has revealed mechanisms used by the virus to evade host antibody responses, many of which involve hypervariability in immunodominant epitopes <a href="#pgen.1000612-Zhou1" rid="pgen.1000612-Zhou1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_569595731">[53]</a>,<a href="#pgen.1000612-Prabakaran1" rid="pgen.1000612-Prabakaran1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_848031068">[54]</a>. Based on this information, immune refocusing (e.g., by retargeted glycosylation, deletion, and/or substitution of amino acids) has been used to dampen the response to variable immunodominant epitopes of the envelope glycoprotein gp160, enabling the host to respond to previously subdominant epitopes <a href="#pgen.1000612-Tobin1" rid="pgen.1000612-Tobin1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_569595705">[55]</a>. High-throughput modification of proteins and their screening for immunogenicity and interaction with antimicrobials is predicted to become more common as techniques evolve <a href="#pgen.1000612-Dormitzer1" rid="pgen.1000612-Dormitzer1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_848031066">[51]</a>.</p></div><div id="s4" class="tsec sec"><h2 class="head no_bottom_margin" id="s4title">The Contribution of Human Genomics</h2><p id="__p23" class="p p-first">When designing new vaccines, one important consideration is the risk that the vaccine might generate &#x0201c;self&#x0201d; immune reactions against host epitopes; immune responses against a pathogen antigen can cross-react with host antigens if homologies exist in the primary amino acid sequence or structure, potentially leading to damage to the host tissue <a href="#pgen.1000612-Ercolini1" rid="pgen.1000612-Ercolini1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_569595745">[56]</a>. Drugs aimed at pathogen targets could also theoretically target similar host molecules. The availability of the human genome sequence combined with methods for predicting B cell and T cell epitopes will facilitate screening for the presence of homologies between candidate microbial vaccine antigens and proteins in humans, enabling issues of autoimmunity and cross-reactivity to be tackled <a href="#pgen.1000612-Amela1" rid="pgen.1000612-Amela1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_569595727">[57]</a>. As such, vaccine or drug targets identified using methods based on pathogen genomics should be screened for homology or similarity to human proteins in silico, using programs such as BLAST (Basic Local Alignment Search Tool; <a href="http://blast.ncbi.nlm.nih.gov/Blast.cgi" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">http://blast.ncbi.nlm.nih.gov/Blast.cgi</a>) to query human genome databases. Interestingly, analysis of 30 viral genomes revealed that around 90&#x00025; of viral pentapeptides, which could be components of epitopes, are identical to human peptides <a href="#pgen.1000612-Kanduc1" rid="pgen.1000612-Kanduc1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_848031070">[58]</a>. There is little homology, however, between validated immunogenic disease-associated peptides/epitopes and host peptides <a href="#pgen.1000612-Amela1" rid="pgen.1000612-Amela1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_569595719">[57]</a>,<a href="#pgen.1000612-Kanduc2" rid="pgen.1000612-Kanduc2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_569595723">[59]</a>, suggesting that screening approaches that include prediction of immunogenicity could improve the pool of target candidates.</p><p id="__p24">It is important to keep in mind that we do not fully understand how self-tolerance is broken, so we currently have no perfect way of predicting all potential autoimmune triggers that could be associated with vaccination. While many links have been made between autoimmune disease and vaccination, they have been confirmed in only a small number of cases (reviewed in <a href="#pgen.1000612-Wraith1" rid="pgen.1000612-Wraith1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_569595755">[60]</a>). For example, treatment-resistant Lyme arthritis is associated in certain patients with immune reactivity to the outer surface protein A (OspA) of the causative agent of Lyme disease, <em>Borrelia burgdorferi</em>, and an OspA epitope (OspA165&#x02013;173) has homology to the human lymphocyte function-associated antigen (hLFA)-1&#x003b1;L <a href="#pgen.1000612-Gross1" rid="pgen.1000612-Gross1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_569595746">[61]</a>. As a result, the OspA-based Lyme disease vaccine (LYMErix) was taken off the market in 2002, but a recombinant OspA lacking the potentially autoreactive T cell epitope has been proposed as a replacement vaccine <a href="#pgen.1000612-Willett1" rid="pgen.1000612-Willett1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_569595737">[62]</a>.</p><p id="__p25">Rather than targeting drugs to pathogen enzymes, an alternative approach has focused on targeting the host-cell proteins that are exploited by pathogens for replication and survival. The use of techniques including microarray-based analysis of virus-induced host gene expression has revealed several possible targets <a href="#pgen.1000612-Kellam1" rid="pgen.1000612-Kellam1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_569595724">[63]</a>,<a href="#pgen.1000612-Andeweg1" rid="pgen.1000612-Andeweg1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_848031069">[64]</a>. The cholesterol-lowering drugs statins, for example, have an anti-HIV effect that is believed to be mediated by preventing activation of the host protein Rho, which is activated by the HIV envelope protein and required for virus entry to the cell <a href="#pgen.1000612-delReal1" rid="pgen.1000612-delReal1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_569595704">[65]</a>. Furthermore, such studies can improve our understanding of the host immune responses that protect against a pathogen (i.e., innate, antibody, Th1, or Th2 responses), which will aid the selection of appropriate vaccine adjuvants. For example, induction of interferon signaling early in infection may be critical to confer protection against SARS-CoV, as determined from functional genomic studies of early host responses to SARS-CoV infection in the lungs of macaques <a href="#pgen.1000612-deLang1" rid="pgen.1000612-deLang1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_569595712">[66]</a>.</p><p id="__p26" class="p p-last">Many of the genes of the human immune system are highly polymorphic, which enables the population as a whole to generate sufficient immunological diversity to combat EIDs. This variation also impacts on the outcome of vaccination and treatment. The International HapMap Project has identified over 3.1 million SNPs in 270 individuals <a href="#pgen.1000612-International1" rid="pgen.1000612-International1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_569595765">[67]</a> and the 1000 Genomes Project aims to identify even more genetic variants. The field of vaccinomics (also called immunogenetics) investigates heterogeneity in host genetic markers that results in variations in vaccine-induced immune responses, with the aim of predicting and minimizing vaccine failures or adverse events <a href="#pgen.1000612-Poland1" rid="pgen.1000612-Poland1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_569595747">[68]</a>. For example, polymorphisms of HLA and immunoregulatory cytokine receptor genes are associated with variable outcomes of vaccination against mumps <a href="#pgen.1000612-Ovsyannikova1" rid="pgen.1000612-Ovsyannikova1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_569595773">[69]</a>. Similarly, pharmacogenetics, which investigates genetic differences in the way individuals metabolize therapeutics, has found that human variability in the speed of metabolism of the common first-line tuberculosis drug isoniazid is associated with genetic variants, including SNPs, in the gene encoding arylamine N-acetyltransferase (NAT2) <a href="#pgen.1000612-Sim1" rid="pgen.1000612-Sim1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_569595736">[70]</a>,<a href="#pgen.1000612-Baudhuin1" rid="pgen.1000612-Baudhuin1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_569595734">[71]</a>. The ability to predict an individual\'s response to a vaccine or drug, may eventually allow physicians to determine whether a patient is genetically susceptible to a disease, the possible adverse effects of a vaccine or drug, and the appropriate schedule or dose to use.</p></div><div id="s5" class="tsec sec"><h2 class="head no_bottom_margin" id="s5title">Challenges for the Future</h2><p id="__p27" class="p p-first-last">We predict that genomics will greatly aid the control of EIDs because of the increased efficiency with which vaccine and therapeutic targets can be identified using the genome-based approaches described above. Furthermore, we anticipate the continual refinement and development of novel genome-based approaches as sequencing becomes faster and more affordable. Several challenges remain, however, in the identification of these targets and in the processes needed to bring a new vaccine or drug to the market. Understanding the molecular nature of epitopes, the mechanisms of action of adjuvants, and T cell and mucosal immunity are key priorities to be tackled in the coming years <a href="#pgen.1000612-Rappuoli1" rid="pgen.1000612-Rappuoli1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_569595754">[3]</a>. These issues can be addressed by improved structural studies of antigen epitopes and the compilation of databases containing information on structure, immunogenicity, and in silico B cell and T cell epitope predictions. Genome-based development of effective vaccines and therapeutics is still largely dependent on the availability of valid models to measure efficacy and protection against disease; however, the increased understanding of microbial pathogenesis that is emerging from genomics should greatly aid in this respect. Likewise, the continued development of animal models with knockout and allele-specific mutations in key components of the immune response will greatly increase understanding of the type of immune response needed to control disease and the ways in which the immune system can be programmed to protect the host against disease. Unfortunately, the stepwise series of prelicensure clinical trials (Phase I, II, and III) that are required to document the safety, immunogenicity, and efficacy of a vaccine are still highly time-consuming and costly. We can only hope that the increasingly &#x0201c;smart&#x0201d; identification and design of targets, and the fresh impetuous given to the fields of vaccine and drug development by the arrival of genomics, will enable increased success of those vaccines and drugs that do make it into clinical development.</p></div><div id="idm139696581159504" class="tsec sec"><h2 class="head no_bottom_margin" id="idm139696581159504title">Footnotes</h2><!--back/fn-group--><div class="fm-sec half_rhythm small"><p class="fn sec" id="idm139696581159376"><p id="__p28" class="p p-first-last">KLS and RR are employed by Novartis Vaccines.</p></p><p class="fn sec" id="idm139696581158512"><p id="__p29" class="p p-first-last">KLS is the recipient of an Australian NHMRC CJ Martin Fellowship. GD is supported by The Wellcome Trust. KLS and RR are employed by Novartis Vaccines. The funders had no role in the preparation of the article.</p></p></div></div><div id="idm139696568034944" class="tsec sec"><h2 class="head no_bottom_margin" id="idm139696568034944title">References</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="pgen.1000612-Dong1">1. <span class="element-citation">Dong J, Olano JP, McBride JW, Walker DH. Emerging pathogens: Challenges and successes of molecular diagnostics. <span><span class="ref-journal">J Mol Diagn. </span>2008;<span class="ref-vol">10</span>:185\xe2\x80\x93197.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2329782/">PMC free article</a>]</span> [<a href="/pubmed/18403608" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Mol+Diagn&amp;title=Emerging+pathogens:+Challenges+and+successes+of+molecular+diagnostics.&amp;author=J+Dong&amp;author=JP+Olano&amp;author=JW+McBride&amp;author=DH+Walker&amp;volume=10&amp;publication_year=2008&amp;pages=185-197&amp;pmid=18403608&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pgen.1000612-Yang1">2. <span class="element-citation">Yang X, Yang H, Zhou G, Zhao GP. Infectious disease in the genomic era. <span><span class="ref-journal">Annu Rev Genomics Hum Genet. </span>2008;<span class="ref-vol">9</span>:21\xe2\x80\x9348.</span> [<a href="/pubmed/18767959" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Annu+Rev+Genomics+Hum+Genet&amp;title=Infectious+disease+in+the+genomic+era.&amp;author=X+Yang&amp;author=H+Yang&amp;author=G+Zhou&amp;author=GP+Zhao&amp;volume=9&amp;publication_year=2008&amp;pages=21-48&amp;pmid=18767959&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pgen.1000612-Rappuoli1">3. <span class="element-citation">Rappuoli R. Bridging the knowledge gaps in vaccine design. <span><span class="ref-journal">Nat Biotechnol. </span>2007;<span class="ref-vol">25</span>:1361\xe2\x80\x931366.</span> [<a href="/pubmed/18066025" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Biotechnol&amp;title=Bridging+the+knowledge+gaps+in+vaccine+design.&amp;author=R+Rappuoli&amp;volume=25&amp;publication_year=2007&amp;pages=1361-1366&amp;pmid=18066025&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pgen.1000612-Fleischmann1">4. <span class="element-citation">Fleischmann RD, Adams MD, White O, Clayton RA, Kirkness EF, et al.  Whole-genome random sequencing and assembly of <em>Haemophilus influenzae</em> Rd. <span><span class="ref-journal">Science. </span>1995;<span class="ref-vol">269</span>:496\xe2\x80\x93512.</span> [<a href="/pubmed/7542800" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=Whole-genome+random+sequencing+and+assembly+of+Haemophilus+influenzae+Rd.&amp;author=RD+Fleischmann&amp;author=MD+Adams&amp;author=O+White&amp;author=RA+Clayton&amp;author=EF+Kirkness&amp;volume=269&amp;publication_year=1995&amp;pages=496-512&amp;pmid=7542800&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pgen.1000612-Casanova1">5. <span class="element-citation">Casanova JL, Abel L. Human genetics of infectious diseases: A unified theory. <span><span class="ref-journal">EMBO J. </span>2007;<span class="ref-vol">26</span>:915\xe2\x80\x93922.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1852849/">PMC free article</a>]</span> [<a href="/pubmed/17255931" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=EMBO+J&amp;title=Human+genetics+of+infectious+diseases:+A+unified+theory.&amp;author=JL+Casanova&amp;author=L+Abel&amp;volume=26&amp;publication_year=2007&amp;pages=915-922&amp;pmid=17255931&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pgen.1000612-Burgner1">6. <span class="element-citation">Burgner D, Jamieson SE, Blackwell JM. Genetic susceptibility to infectious diseases: Big is beautiful, but will bigger be even better? <span><span class="ref-journal">Lancet Infect Dis. </span>2006;<span class="ref-vol">6</span>:653\xe2\x80\x93663.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2330096/">PMC free article</a>]</span> [<a href="/pubmed/17008174" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Lancet+Infect+Dis&amp;title=Genetic+susceptibility+to+infectious+diseases:+Big+is+beautiful,+but+will+bigger+be+even+better?&amp;author=D+Burgner&amp;author=SE+Jamieson&amp;author=JM+Blackwell&amp;volume=6&amp;publication_year=2006&amp;pages=653-663&amp;pmid=17008174&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pgen.1000612-Nakamura1">7. <span class="element-citation">Nakamura S, Yang CS, Sakon N, Ueda M, Tougan T, et al.  Direct metagenomic detection of viral pathogens in nasal and fecal specimens using an unbiased high-throughput sequencing approach. <span><span class="ref-journal">PLoS ONE. </span>2009;<span class="ref-vol">4</span>:e4219.</span> doi: <a href="http://dx.doi.org/10.1371/journal.pone.0004219" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=External%7CLink%7CURI" target="_blank">10.1371/journal.pone.0004219</a>. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2625441/">PMC free article</a>]</span> [<a href="/pubmed/19156205" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PLoS+ONE&amp;title=Direct+metagenomic+detection+of+viral+pathogens+in+nasal+and+fecal+specimens+using+an+unbiased+high-throughput+sequencing+approach.&amp;author=S+Nakamura&amp;author=CS+Yang&amp;author=N+Sakon&amp;author=M+Ueda&amp;author=T+Tougan&amp;volume=4&amp;publication_year=2009&amp;pages=e4219&amp;pmid=19156205&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pgen.1000612-Bittar1">8. <span class="element-citation">Bittar F, Richet H, Dubus JC, Reynaud-Gaubert M, Stremler N, et al.  Molecular detection of multiple emerging pathogens in sputa from cystic fibrosis patients. <span><span class="ref-journal">PLoS ONE. </span>2008;<span class="ref-vol">3</span>:e2908.</span> doi: <a href="http://dx.doi.org/10.1371/journal.pone.0002908" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=External%7CLink%7CURI" target="_blank">10.1371/journal.pone.0002908</a>. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2483419/">PMC free article</a>]</span> [<a href="/pubmed/18682840" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PLoS+ONE&amp;title=Molecular+detection+of+multiple+emerging+pathogens+in+sputa+from+cystic+fibrosis+patients.&amp;author=F+Bittar&amp;author=H+Richet&amp;author=JC+Dubus&amp;author=M+Reynaud-Gaubert&amp;author=N+Stremler&amp;volume=3&amp;publication_year=2008&amp;pages=e2908&amp;pmid=18682840&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pgen.1000612-Rinaudo1">9. <span class="element-citation">Rinaudo CD, Telford JL, Rappuoli R, Seib KL. Vaccinology in the genome era. <span><span class="ref-journal">J Clin Invest. </span>2009;<span class="ref-vol">119</span>:2515\xe2\x80\x932525.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2735939/">PMC free article</a>]</span> [<a href="/pubmed/19729849" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Invest&amp;title=Vaccinology+in+the+genome+era.&amp;author=CD+Rinaudo&amp;author=JL+Telford&amp;author=R+Rappuoli&amp;author=KL+Seib&amp;volume=119&amp;publication_year=2009&amp;pages=2515-2525&amp;pmid=19729849&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pgen.1000612-Kaushik1">10. <span class="element-citation">Kaushik DK, Sehgal D. Developing antibacterial vaccines in genomics and proteomics era. <span><span class="ref-journal">Scand J Immunol. </span>2008;<span class="ref-vol">67</span>:544\xe2\x80\x93552.</span> [<a href="/pubmed/18397199" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Scand+J+Immunol&amp;title=Developing+antibacterial+vaccines+in+genomics+and+proteomics+era.&amp;author=DK+Kaushik&amp;author=D+Sehgal&amp;volume=67&amp;publication_year=2008&amp;pages=544-552&amp;pmid=18397199&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pgen.1000612-Pucci1">11. <span class="element-citation">Pucci MJ. Novel genetic techniques and approaches in the microbial genomics era: identification and/or validation of targets for the discovery of new antibacterial agents. <span><span class="ref-journal">Drugs R D. </span>2007;<span class="ref-vol">8</span>:201\xe2\x80\x93212.</span> [<a href="/pubmed/17596107" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Drugs+R+D&amp;title=Novel+genetic+techniques+and+approaches+in+the+microbial+genomics+era:+identification+and/or+validation+of+targets+for+the+discovery+of+new+antibacterial+agents.&amp;author=MJ+Pucci&amp;volume=8&amp;publication_year=2007&amp;pages=201-212&amp;pmid=17596107&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pgen.1000612-Mills1">12. <span class="element-citation">Mills SD. When will the genomics investment pay off for antibacterial discovery? <span><span class="ref-journal">Biochem Pharmacol. </span>2006;<span class="ref-vol">71</span>:1096\xe2\x80\x931102.</span> [<a href="/pubmed/16387281" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biochem+Pharmacol&amp;title=When+will+the+genomics+investment+pay+off+for+antibacterial+discovery?&amp;author=SD+Mills&amp;volume=71&amp;publication_year=2006&amp;pages=1096-1102&amp;pmid=16387281&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pgen.1000612-VanVoorhis1">13. <span class="element-citation">Van Voorhis WC, Hol WGJ, Myler PJ, Stewart LJ. The role of medical structural genomics in discovering new drugs for infectious diseases. <span><span class="ref-journal">PLoS Comput Biol. </span>2009;<span class="ref-vol">5(10)</span>:e530.</span> 10.1371/journal.pcbi.1000530. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2756625/">PMC free article</a>]</span> [<a href="/pubmed/19855826" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PLoS+Comput+Biol&amp;title=The+role+of+medical+structural+genomics+in+discovering+new+drugs+for+infectious+diseases.&amp;author=WC+Van+Voorhis&amp;author=WGJ+Hol&amp;author=PJ+Myler&amp;author=LJ+Stewart&amp;volume=5(10)&amp;publication_year=2009&amp;pages=e530&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pgen.1000612-Masignani1">14. <span class="element-citation">Masignani V, Rappuoli R, Pizza M. Reverse vaccinology: A genome-based approach for vaccine development. <span><span class="ref-journal">Expert Opin Biol Ther. </span>2002;<span class="ref-vol">2</span>:895\xe2\x80\x93905.</span> [<a href="/pubmed/12517268" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Expert+Opin+Biol+Ther&amp;title=Reverse+vaccinology:+A+genome-based+approach+for+vaccine+development.&amp;author=V+Masignani&amp;author=R+Rappuoli&amp;author=M+Pizza&amp;volume=2&amp;publication_year=2002&amp;pages=895-905&amp;pmid=12517268&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pgen.1000612-Pizza1">15. <span class="element-citation">Pizza M, Scarlato V, Masignani V, Giuliani MM, Arico B, et al.  Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing. <span><span class="ref-journal">Science. </span>2000;<span class="ref-vol">287</span>:1816\xe2\x80\x931820.</span> [<a href="/pubmed/10710308" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=Identification+of+vaccine+candidates+against+serogroup+B+meningococcus+by+whole-genome+sequencing.&amp;author=M+Pizza&amp;author=V+Scarlato&amp;author=V+Masignani&amp;author=MM+Giuliani&amp;author=B+Arico&amp;volume=287&amp;publication_year=2000&amp;pages=1816-1820&amp;pmid=10710308&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pgen.1000612-Giuliani1">16. <span class="element-citation">Giuliani MM, Adu-Bobie J, Comanducci M, Arico B, Savino S, et al.  A universal vaccine for serogroup B meningococcus. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2006;<span class="ref-vol">103</span>:10834\xe2\x80\x9310839.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2047628/">PMC free article</a>]</span> [<a href="/pubmed/16825336" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+U+S+A&amp;title=A+universal+vaccine+for+serogroup+B+meningococcus.&amp;author=MM+Giuliani&amp;author=J+Adu-Bobie&amp;author=M+Comanducci&amp;author=B+Arico&amp;author=S+Savino&amp;volume=103&amp;publication_year=2006&amp;pages=10834-10839&amp;pmid=16825336&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pgen.1000612-Rappuoli2">17. <span class="element-citation">Rappuoli R. The application of reverse vaccinology, Novartis MenB vaccine developed by design. 2008. 81.  16th International Pathogenic Neisseria Conference, Rotterdam, The Netherlands:  <a href="http://www.IPNC2008.org" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=External%7CLink%7CURI" target="_blank">http://www.IPNC2008.org</a>. Abstr.</span></div><div class="ref-cit-blk half_rhythm" id="pgen.1000612-Muzzi1">18. <span class="element-citation">Muzzi A, Masignani V, Rappuoli R. The pan-genome: Towards a knowledge-based discovery of novel targets for vaccines and antibacterials. <span><span class="ref-journal">Drug Discov Today. </span>2007;<span class="ref-vol">12</span>:429\xe2\x80\x93439.</span> [<a href="/pubmed/17532526" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Drug+Discov+Today&amp;title=The+pan-genome:+Towards+a+knowledge-based+discovery+of+novel+targets+for+vaccines+and+antibacterials.&amp;author=A+Muzzi&amp;author=V+Masignani&amp;author=R+Rappuoli&amp;volume=12&amp;publication_year=2007&amp;pages=429-439&amp;pmid=17532526&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pgen.1000612-Tettelin1">19. <span class="element-citation">Tettelin H, Masignani V, Cieslewicz MJ, Donati C, Medini D, et al.  Genome analysis of multiple pathogenic isolates of <em>Streptococcus agalactiae</em>: implications for the microbial &#x0201c;pan-genome.&#x0201d; <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2005;<span class="ref-vol">102</span>:13950\xe2\x80\x9313955.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1216834/">PMC free article</a>]</span> [<a href="/pubmed/16172379" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+U+S+A&amp;title=Genome+analysis+of+multiple+pathogenic+isolates+of+Streptococcus+agalactiae:+implications+for+the+microbial+&#x0201c;pan-genome.&#x0201d;&amp;author=H+Tettelin&amp;author=V+Masignani&amp;author=MJ+Cieslewicz&amp;author=C+Donati&amp;author=D+Medini&amp;volume=102&amp;publication_year=2005&amp;pages=13950-13955&amp;pmid=16172379&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pgen.1000612-Maione1">20. <span class="element-citation">Maione D, Margarit I, Rinaudo CD, Masignani V, Mora M, et al.  Identification of a universal Group B streptococcus vaccine by multiple genome screen. <span><span class="ref-journal">Science. </span>2005;<span class="ref-vol">309</span>:148\xe2\x80\x93150.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1351092/">PMC free article</a>]</span> [<a href="/pubmed/15994562" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=Identification+of+a+universal+Group+B+streptococcus+vaccine+by+multiple+genome+screen.&amp;author=D+Maione&amp;author=I+Margarit&amp;author=CD+Rinaudo&amp;author=V+Masignani&amp;author=M+Mora&amp;volume=309&amp;publication_year=2005&amp;pages=148-150&amp;pmid=15994562&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pgen.1000612-Bhagwat1">21. <span class="element-citation">Bhagwat AA, Bhagwat M. Methods and tools for comparative genomics of foodborne pathogens. <span><span class="ref-journal">Foodborne Pathog Dis. </span>2008;<span class="ref-vol">5</span>:487\xe2\x80\x93497.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2614369/">PMC free article</a>]</span> [<a href="/pubmed/18713064" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Foodborne+Pathog+Dis&amp;title=Methods+and+tools+for+comparative+genomics+of+foodborne+pathogens.&amp;author=AA+Bhagwat&amp;author=M+Bhagwat&amp;volume=5&amp;publication_year=2008&amp;pages=487-497&amp;pmid=18713064&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pgen.1000612-Rasko1">22. <span class="element-citation">Rasko DA, Rosovitz MJ, Myers GS, Mongodin EF, Fricke WF, et al.  The pangenome structure of <em>Escherichia coli</em>: Comparative genomic analysis of <em>E. coli</em> commensal and pathogenic isolates. <span><span class="ref-journal">J Bacteriol. </span>2008;<span class="ref-vol">190</span>:6881\xe2\x80\x936893.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2566221/">PMC free article</a>]</span> [<a href="/pubmed/18676672" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Bacteriol&amp;title=The+pangenome+structure+of+Escherichia+coli:+Comparative+genomic+analysis+of+E.+coli+commensal+and+pathogenic+isolates.&amp;author=DA+Rasko&amp;author=MJ+Rosovitz&amp;author=GS+Myers&amp;author=EF+Mongodin&amp;author=WF+Fricke&amp;volume=190&amp;publication_year=2008&amp;pages=6881-6893&amp;pmid=18676672&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pgen.1000612-Holt1">23. <span class="element-citation">Holt KE, Parkhill J, Mazzoni CJ, Roumagnac P, Weill FX, et al.  High-throughput sequencing provides insights into genome variation and evolution in <em>Salmonella typhi</em>. <span><span class="ref-journal">Nat Genet. </span>2008;<span class="ref-vol">40</span>:987\xe2\x80\x93993.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2652037/">PMC free article</a>]</span> [<a href="/pubmed/18660809" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Genet&amp;title=High-throughput+sequencing+provides+insights+into+genome+variation+and+evolution+in+Salmonella+typhi.&amp;author=KE+Holt&amp;author=J+Parkhill&amp;author=CJ+Mazzoni&amp;author=P+Roumagnac&amp;author=FX+Weill&amp;volume=40&amp;publication_year=2008&amp;pages=987-993&amp;pmid=18660809&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pgen.1000612-Dhiman1">24. <span class="element-citation">Dhiman N, Bonilla R, O\'Kane DJ, Poland GA. Gene expression microarrays: A 21st century tool for directed vaccine design. <span><span class="ref-journal">Vaccine. </span>2001;<span class="ref-vol">20</span>:22\xe2\x80\x9330.</span> [<a href="/pubmed/11567742" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Vaccine&amp;title=Gene+expression+microarrays:+A+21st+century+tool+for+directed+vaccine+design.&amp;author=N+Dhiman&amp;author=R+Bonilla&amp;author=DJ+O\'Kane&amp;author=GA+Poland&amp;volume=20&amp;publication_year=2001&amp;pages=22-30&amp;pmid=11567742&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pgen.1000612-Morozova1">25. <span class="element-citation">Morozova O, Marra MA. Applications of next-generation sequencing technologies in functional genomics. <span><span class="ref-journal">Genomics. </span>2008;<span class="ref-vol">92</span>:255\xe2\x80\x93264.</span> [<a href="/pubmed/18703132" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Genomics&amp;title=Applications+of+next-generation+sequencing+technologies+in+functional+genomics.&amp;author=O+Morozova&amp;author=MA+Marra&amp;volume=92&amp;publication_year=2008&amp;pages=255-264&amp;pmid=18703132&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pgen.1000612-Merrell1">26. <span class="element-citation">Merrell DS, Butler SM, Qadri F, Dolganov NA, Alam A, et al.  Host-induced epidemic spread of the cholera bacterium. <span><span class="ref-journal">Nature. </span>2002;<span class="ref-vol">417</span>:642\xe2\x80\x93645.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2776822/">PMC free article</a>]</span> [<a href="/pubmed/12050664" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Host-induced+epidemic+spread+of+the+cholera+bacterium.&amp;author=DS+Merrell&amp;author=SM+Butler&amp;author=F+Qadri&amp;author=NA+Dolganov&amp;author=A+Alam&amp;volume=417&amp;publication_year=2002&amp;pages=642-645&amp;pmid=12050664&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pgen.1000612-Talaat1">27. <span class="element-citation">Talaat AM, Lyons R, Howard ST, Johnston SA. The temporal expression profile of <em>Mycobacterium tuberculosis</em> infection in mice. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2004;<span class="ref-vol">101</span>:4602\xe2\x80\x934607.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC384793/">PMC free article</a>]</span> [<a href="/pubmed/15070764" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+U+S+A&amp;title=The+temporal+expression+profile+of+Mycobacterium+tuberculosis+infection+in+mice.&amp;author=AM+Talaat&amp;author=R+Lyons&amp;author=ST+Howard&amp;author=SA+Johnston&amp;volume=101&amp;publication_year=2004&amp;pages=4602-4607&amp;pmid=15070764&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pgen.1000612-Scarselli1">28. <span class="element-citation">Scarselli M, Giuliani MM, Adu-Bobie J, Pizza M, Rappuoli R. The impact of genomics on vaccine design. <span><span class="ref-journal">Trends Biotechnol. </span>2005;<span class="ref-vol">23</span>:84\xe2\x80\x9391.</span> [<a href="/pubmed/15661345" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Trends+Biotechnol&amp;title=The+impact+of+genomics+on+vaccine+design.&amp;author=M+Scarselli&amp;author=MM+Giuliani&amp;author=J+Adu-Bobie&amp;author=M+Pizza&amp;author=R+Rappuoli&amp;volume=23&amp;publication_year=2005&amp;pages=84-91&amp;pmid=15661345&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pgen.1000612-Saenz1">29. <span class="element-citation">Saenz HL, Dehio C. Signature-tagged mutagenesis: technical advances in a negative selection method for virulence gene identification. <span><span class="ref-journal">Curr Opin Microbiol. </span>2005;<span class="ref-vol">8</span>:612\xe2\x80\x93619.</span> [<a href="/pubmed/16126452" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Curr+Opin+Microbiol&amp;title=Signature-tagged+mutagenesis:+technical+advances+in+a+negative+selection+method+for+virulence+gene+identification.&amp;author=HL+Saenz&amp;author=C+Dehio&amp;volume=8&amp;publication_year=2005&amp;pages=612-619&amp;pmid=16126452&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pgen.1000612-Sakata1">30. <span class="element-citation">Sakata T, Winzeler EA. Genomics, systems biology and drug development for infectious diseases. <span><span class="ref-journal">Mol Biosyst. </span>2007;<span class="ref-vol">3</span>:841\xe2\x80\x93848.</span> [<a href="/pubmed/18000561" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Biosyst&amp;title=Genomics,+systems+biology+and+drug+development+for+infectious+diseases.&amp;author=T+Sakata&amp;author=EA+Winzeler&amp;volume=3&amp;publication_year=2007&amp;pages=841-848&amp;pmid=18000561&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pgen.1000612-Sun1">31. <span class="element-citation">Sun YH, Bakshi S, Chalmers R, Tang CM. Functional genomics of <em>Neisseria meningitidis</em> pathogenesis. <span><span class="ref-journal">Nat Med. </span>2000;<span class="ref-vol">6</span>:1269\xe2\x80\x931273.</span> [<a href="/pubmed/11062540" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Med&amp;title=Functional+genomics+of+Neisseria+meningitidis+pathogenesis.&amp;author=YH+Sun&amp;author=S+Bakshi&amp;author=R+Chalmers&amp;author=CM+Tang&amp;volume=6&amp;publication_year=2000&amp;pages=1269-1273&amp;pmid=11062540&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pgen.1000612-Kavermann1">32. <span class="element-citation">Kavermann H, Burns BP, Angermuller K, Odenbreit S, Fischer W, et al.  Identification and characterization of <em>Helicobacter pylori</em> genes essential for gastric colonization. <span><span class="ref-journal">J Exp Med. </span>2003;<span class="ref-vol">197</span>:813\xe2\x80\x93822.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2193887/">PMC free article</a>]</span> [<a href="/pubmed/12668646" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Exp+Med&amp;title=Identification+and+characterization+of+Helicobacter+pylori+genes+essential+for+gastric+colonization.&amp;author=H+Kavermann&amp;author=BP+Burns&amp;author=K+Angermuller&amp;author=S+Odenbreit&amp;author=W+Fischer&amp;volume=197&amp;publication_year=2003&amp;pages=813-822&amp;pmid=12668646&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pgen.1000612-Sassetti1">33. <span class="element-citation">Sassetti CM, Boyd DH, Rubin EJ. Genes required for mycobacterial growth defined by high density mutagenesis. <span><span class="ref-journal">Mol Microbiol. </span>2003;<span class="ref-vol">48</span>:77\xe2\x80\x9384.</span> [<a href="/pubmed/12657046" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Microbiol&amp;title=Genes+required+for+mycobacterial+growth+defined+by+high+density+mutagenesis.&amp;author=CM+Sassetti&amp;author=DH+Boyd&amp;author=EJ+Rubin&amp;volume=48&amp;publication_year=2003&amp;pages=77-84&amp;pmid=12657046&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pgen.1000612-Zhu1">34. <span class="element-citation">Zhu H, Bilgin M, Snyder M. Proteomics. <span><span class="ref-journal">Annu Rev Biochem. </span>2003;<span class="ref-vol">72</span>:783\xe2\x80\x93812.</span> [<a href="/pubmed/14527327" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Annu+Rev+Biochem&amp;title=Proteomics.&amp;author=H+Zhu&amp;author=M+Bilgin&amp;author=M+Snyder&amp;volume=72&amp;publication_year=2003&amp;pages=783-812&amp;pmid=14527327&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pgen.1000612-Grandi1">35. <span class="element-citation">Grandi G. Genomics and proteomics in reverse vaccines. <span><span class="ref-journal">Methods Biochem Anal. </span>2006;<span class="ref-vol">49</span>:379\xe2\x80\x93393.</span> [<a href="/pubmed/16929688" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Methods+Biochem+Anal&amp;title=Genomics+and+proteomics+in+reverse+vaccines.&amp;author=G+Grandi&amp;volume=49&amp;publication_year=2006&amp;pages=379-393&amp;pmid=16929688&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pgen.1000612-RodriguezOrtega1">36. <span class="element-citation">Rodriguez-Ortega MJ, Norais N, Bensi G, Liberatori S, Capo S, et al.  Characterization and identification of vaccine candidate proteins through analysis of the group A Streptococcus surface proteome. <span><span class="ref-journal">Nat Biotechnol. </span>2006;<span class="ref-vol">24</span>:191\xe2\x80\x93197.</span> [<a href="/pubmed/16415855" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Biotechnol&amp;title=Characterization+and+identification+of+vaccine+candidate+proteins+through+analysis+of+the+group+A+Streptococcus+surface+proteome.&amp;author=MJ+Rodriguez-Ortega&amp;author=N+Norais&amp;author=G+Bensi&amp;author=S+Liberatori&amp;author=S+Capo&amp;volume=24&amp;publication_year=2006&amp;pages=191-197&amp;pmid=16415855&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pgen.1000612-DeGroot1">37. <span class="element-citation">De Groot AS, McMurry J, Moise L. Prediction of immunogenicity: in silico paradigms, ex vivo and in vivo correlates. <span><span class="ref-journal">Curr Opin Pharmacol. </span>2008;<span class="ref-vol">8</span>:620\xe2\x80\x93626.</span> [<a href="/pubmed/18775515" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Curr+Opin+Pharmacol&amp;title=Prediction+of+immunogenicity:+in+silico+paradigms,+ex+vivo+and+in+vivo+correlates.&amp;author=AS+De+Groot&amp;author=J+McMurry&amp;author=L+Moise&amp;volume=8&amp;publication_year=2008&amp;pages=620-626&amp;pmid=18775515&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pgen.1000612-Meinke1">38. <span class="element-citation">Meinke A, Henics T, Hanner M, Minh DB, Nagy E. Antigenome technology: A novel approach for the selection of bacterial vaccine candidate antigens. <span><span class="ref-journal">Vaccine. </span>2005;<span class="ref-vol">23</span>:2035\xe2\x80\x932041.</span> [<a href="/pubmed/15755567" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Vaccine&amp;title=Antigenome+technology:+A+novel+approach+for+the+selection+of+bacterial+vaccine+candidate+antigens.&amp;author=A+Meinke&amp;author=T+Henics&amp;author=M+Hanner&amp;author=DB+Minh&amp;author=E+Nagy&amp;volume=23&amp;publication_year=2005&amp;pages=2035-2041&amp;pmid=15755567&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pgen.1000612-Vytvytska1">39. <span class="element-citation">Vytvytska O, Nagy E, Bluggel M, Meyer HE, Kurzbauer R, et al.  Identification of vaccine candidate antigens of <em>Staphylococcus aureus</em> by serological proteome analysis. <span><span class="ref-journal">Proteomics. </span>2002;<span class="ref-vol">2</span>:580\xe2\x80\x93590.</span> [<a href="/pubmed/11987132" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proteomics&amp;title=Identification+of+vaccine+candidate+antigens+of+Staphylococcus+aureus+by+serological+proteome+analysis.&amp;author=O+Vytvytska&amp;author=E+Nagy&amp;author=M+Bluggel&amp;author=HE+Meyer&amp;author=R+Kurzbauer&amp;volume=2&amp;publication_year=2002&amp;pages=580-590&amp;pmid=11987132&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pgen.1000612-Giefing1">40. <span class="element-citation">Giefing C, Meinke AL, Hanner M, Henics T, Bui MD, et al.  Discovery of a novel class of highly conserved vaccine antigens using genomic scale antigenic fingerprinting of pneumococcus with human antibodies. <span><span class="ref-journal">J Exp Med. </span>2008;<span class="ref-vol">205</span>:117\xe2\x80\x93131.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2234372/">PMC free article</a>]</span> [<a href="/pubmed/18166586" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Exp+Med&amp;title=Discovery+of+a+novel+class+of+highly+conserved+vaccine+antigens+using+genomic+scale+antigenic+fingerprinting+of+pneumococcus+with+human+antibodies.&amp;author=C+Giefing&amp;author=AL+Meinke&amp;author=M+Hanner&amp;author=T+Henics&amp;author=MD+Bui&amp;volume=205&amp;publication_year=2008&amp;pages=117-131&amp;pmid=18166586&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pgen.1000612-Eyles1">41. <span class="element-citation">Eyles JE, Unal B, Hartley MG, Newstead SL, Flick-Smith H, et al.  Immunodominant <em>Francisella tularensis</em> antigens identified using proteome microarray. <span><span class="ref-journal">Proteomics. </span>2007;<span class="ref-vol">7</span>:2172\xe2\x80\x932183.</span> [<a href="/pubmed/17533643" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proteomics&amp;title=Immunodominant+Francisella+tularensis+antigens+identified+using+proteome+microarray.&amp;author=JE+Eyles&amp;author=B+Unal&amp;author=MG+Hartley&amp;author=SL+Newstead&amp;author=H+Flick-Smith&amp;volume=7&amp;publication_year=2007&amp;pages=2172-2183&amp;pmid=17533643&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pgen.1000612-Rolfs1">42. <span class="element-citation">Rolfs A, Montor WR, Yoon SS, Hu Y, Bhullar B, et al.  Production and sequence validation of a complete full length ORF collection for the pathogenic bacterium <em>Vibrio cholerae</em>. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2008;<span class="ref-vol">105</span>:4364\xe2\x80\x934369.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2393773/">PMC free article</a>]</span> [<a href="/pubmed/18337508" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+U+S+A&amp;title=Production+and+sequence+validation+of+a+complete+full+length+ORF+collection+for+the+pathogenic+bacterium+Vibrio+cholerae.&amp;author=A+Rolfs&amp;author=WR+Montor&amp;author=SS+Yoon&amp;author=Y+Hu&amp;author=B+Bhullar&amp;volume=105&amp;publication_year=2008&amp;pages=4364-4369&amp;pmid=18337508&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pgen.1000612-Stoevesandt1">43. <span class="element-citation">Stoevesandt O, Taussig MJ, He M. Protein microarrays: high-throughput tools for proteomics. <span><span class="ref-journal">Expert Rev Proteomics. </span>2009;<span class="ref-vol">6</span>:145\xe2\x80\x93157.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7105755/">PMC free article</a>]</span> [<a href="/pubmed/19385942" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Expert+Rev+Proteomics&amp;title=Protein+microarrays:+high-throughput+tools+for+proteomics.&amp;author=O+Stoevesandt&amp;author=MJ+Taussig&amp;author=M+He&amp;volume=6&amp;publication_year=2009&amp;pages=145-157&amp;pmid=19385942&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pgen.1000612-DeGroot2">44. <span class="element-citation">De Groot AS, Moise L, McMurry JA, Martin W.  Epitope-based immunone-derived vaccines: a strategy for improved design and safety. In: Falus A, editor. <span class="ref-journal">Clinical Applications of Immunomics.</span> New York: Springer; 2008. pp. 39\xe2\x80\x9369. <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?title=Clinical+Applications+of+Immunomics&amp;author=AS+De+Groot&amp;author=L+Moise&amp;author=JA+McMurry&amp;author=W+Martin&amp;publication_year=2008&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pgen.1000612-Sette1">45. <span class="element-citation">Sette A, Fleri W, Peters B, Sathiamurthy M, Bui HH, et al.  A roadmap for the immunomics of category A-C pathogens. <span><span class="ref-journal">Immunity. </span>2005;<span class="ref-vol">22</span>:155\xe2\x80\x93161.</span> [<a href="/pubmed/15773067" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Immunity&amp;title=A+roadmap+for+the+immunomics+of+category+A-C+pathogens.&amp;author=A+Sette&amp;author=W+Fleri&amp;author=B+Peters&amp;author=M+Sathiamurthy&amp;author=HH+Bui&amp;volume=22&amp;publication_year=2005&amp;pages=155-161&amp;pmid=15773067&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pgen.1000612-DeGroot3">46. <span class="element-citation">De Groot AS, Rivera DS, McMurry JA, Buus S, Martin W. Identification of immunogenic HLA-B7 &#x0201c;Achilles\' heel&#x0201d; epitopes within highly conserved regions of HIV. <span><span class="ref-journal">Vaccine. </span>2008;<span class="ref-vol">26</span>:3059\xe2\x80\x933071.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2553891/">PMC free article</a>]</span> [<a href="/pubmed/18206276" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Vaccine&amp;title=Identification+of+immunogenic+HLA-B7+&#x0201c;Achilles\'+heel&#x0201d;+epitopes+within+highly+conserved+regions+of+HIV.&amp;author=AS+De+Groot&amp;author=DS+Rivera&amp;author=JA+McMurry&amp;author=S+Buus&amp;author=W+Martin&amp;volume=26&amp;publication_year=2008&amp;pages=3059-3071&amp;pmid=18206276&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pgen.1000612-Lundstrom1">47. <span class="element-citation">Lundstrom K. Structural genomics and drug discovery. <span><span class="ref-journal">J Cell Mol Med. </span>2007;<span class="ref-vol">11</span>:224\xe2\x80\x93238.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3822824/">PMC free article</a>]</span> [<a href="/pubmed/17488474" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Cell+Mol+Med&amp;title=Structural+genomics+and+drug+discovery.&amp;author=K+Lundstrom&amp;volume=11&amp;publication_year=2007&amp;pages=224-238&amp;pmid=17488474&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pgen.1000612-Kaldor1">48. <span class="element-citation">Kaldor SW, Kalish VJ, Davies JF, 2nd, Shetty BV, Fritz JE, et al.  Viracept (nelfinavir mesylate, AG1343): A potent, orally bioavailable inhibitor of HIV-1 protease. <span><span class="ref-journal">J Med Chem. </span>1997;<span class="ref-vol">40</span>:3979\xe2\x80\x933985.</span> [<a href="/pubmed/9397180" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Med+Chem&amp;title=Viracept+(nelfinavir+mesylate,+AG1343):+A+potent,+orally+bioavailable+inhibitor+of+HIV-1+protease.&amp;author=SW+Kaldor&amp;author=VJ+Kalish&amp;author=JF+Davies&amp;author=BV+Shetty&amp;author=JE+Fritz&amp;volume=40&amp;publication_year=1997&amp;pages=3979-3985&amp;pmid=9397180&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pgen.1000612-Kim1">49. <span class="element-citation">Kim CU, Lew W, Williams MA, Liu H, Zhang L, et al.  Influenza neuraminidase inhibitors possessing a novel hydrophobic interaction in the enzyme active site: Design, synthesis, and structural analysis of carbocyclic sialic acid analogues with potent anti-influenza activity. <span><span class="ref-journal">J Am Chem Soc. </span>1997;<span class="ref-vol">119</span>:681\xe2\x80\x93690.</span> [<a href="/pubmed/16526129" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Am+Chem+Soc&amp;title=Influenza+neuraminidase+inhibitors+possessing+a+novel+hydrophobic+interaction+in+the+enzyme+active+site:+Design,+synthesis,+and+structural+analysis+of+carbocyclic+sialic+acid+analogues+with+potent+anti-influenza+activity.&amp;author=CU+Kim&amp;author=W+Lew&amp;author=MA+Williams&amp;author=H+Liu&amp;author=L+Zhang&amp;volume=119&amp;publication_year=1997&amp;pages=681-690&amp;pmid=16526129&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pgen.1000612-Todd1">50. <span class="element-citation">Todd AE, Marsden RL, Thornton JM, Orengo CA. Progress of structural genomics initiatives: An analysis of solved target structures. <span><span class="ref-journal">J Mol Biol. </span>2005;<span class="ref-vol">348</span>:1235\xe2\x80\x931260.</span> [<a href="/pubmed/15854658" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Mol+Biol&amp;title=Progress+of+structural+genomics+initiatives:+An+analysis+of+solved+target+structures.&amp;author=AE+Todd&amp;author=RL+Marsden&amp;author=JM+Thornton&amp;author=CA+Orengo&amp;volume=348&amp;publication_year=2005&amp;pages=1235-1260&amp;pmid=15854658&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pgen.1000612-Dormitzer1">51. <span class="element-citation">Dormitzer PR, Ulmer JB, Rappuoli R. Structure-based antigen design: A strategy for next generation vaccines. <span><span class="ref-journal">Trends Biotechnol. </span>2008;<span class="ref-vol">26</span>:659\xe2\x80\x93667.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7114313/">PMC free article</a>]</span> [<a href="/pubmed/18977045" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Trends+Biotechnol&amp;title=Structure-based+antigen+design:+A+strategy+for+next+generation+vaccines.&amp;author=PR+Dormitzer&amp;author=JB+Ulmer&amp;author=R+Rappuoli&amp;volume=26&amp;publication_year=2008&amp;pages=659-667&amp;pmid=18977045&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pgen.1000612-Nicola1">52. <span class="element-citation">Nicola G, Abagyan R. Structure-based approaches to antibiotic drug discovery. <span><span class="ref-journal">Curr Protoc Microbiol Chapter. </span>2009;<span class="ref-vol">17</span>:Unit 17.2.</span> [<a href="/pubmed/19235149" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Curr+Protoc+Microbiol+Chapter&amp;title=Structure-based+approaches+to+antibiotic+drug+discovery.&amp;author=G+Nicola&amp;author=R+Abagyan&amp;volume=17&amp;publication_year=2009&amp;pages=Unit+17.2&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pgen.1000612-Zhou1">53. <span class="element-citation">Zhou T, Xu L, Dey B, Hessell AJ, Van Ryk D, et al.  Structural definition of a conserved neutralization epitope on HIV-1 gp120. <span><span class="ref-journal">Nature. </span>2007;<span class="ref-vol">445</span>:732\xe2\x80\x93737.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2584968/">PMC free article</a>]</span> [<a href="/pubmed/17301785" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Structural+definition+of+a+conserved+neutralization+epitope+on+HIV-1+gp120.&amp;author=T+Zhou&amp;author=L+Xu&amp;author=B+Dey&amp;author=AJ+Hessell&amp;author=D+Van+Ryk&amp;volume=445&amp;publication_year=2007&amp;pages=732-737&amp;pmid=17301785&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pgen.1000612-Prabakaran1">54. <span class="element-citation">Prabakaran P, Dimitrov AS, Fouts TR, Dimitrov DS, KuanTeh J.  <span class="ref-journal">Advances in Pharmacology.</span> Academic Press; 2007. Structure and function of the HIV envelope glycoprotein as entry mediator, vaccine immunogen, and target for inhibitors. pp. 33\xe2\x80\x9397. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7111665/">PMC free article</a>]</span> [<a href="/pubmed/17586312" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?title=Advances+in+Pharmacology&amp;author=P+Prabakaran&amp;author=AS+Dimitrov&amp;author=TR+Fouts&amp;author=DS+Dimitrov&amp;author=J+KuanTeh&amp;publication_year=2007&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pgen.1000612-Tobin1">55. <span class="element-citation">Tobin GJ, Trujillo JD, Bushnell RV, Lin G, Chaudhuri AR, et al.  Deceptive imprinting and immune refocusing in vaccine design. <span><span class="ref-journal">Vaccine. </span>2008;<span class="ref-vol">26</span>:6189\xe2\x80\x936199.</span> [<a href="/pubmed/18852005" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Vaccine&amp;title=Deceptive+imprinting+and+immune+refocusing+in+vaccine+design.&amp;author=GJ+Tobin&amp;author=JD+Trujillo&amp;author=RV+Bushnell&amp;author=G+Lin&amp;author=AR+Chaudhuri&amp;volume=26&amp;publication_year=2008&amp;pages=6189-6199&amp;pmid=18852005&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pgen.1000612-Ercolini1">56. <span class="element-citation">Ercolini AM, Miller SD. The role of infections in autoimmune disease. <span><span class="ref-journal">Clin Exp Immunol. </span>2009;<span class="ref-vol">155</span>:1\xe2\x80\x9315.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2665673/">PMC free article</a>]</span> [<a href="/pubmed/19076824" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Exp+Immunol&amp;title=The+role+of+infections+in+autoimmune+disease.&amp;author=AM+Ercolini&amp;author=SD+Miller&amp;volume=155&amp;publication_year=2009&amp;pages=1-15&amp;pmid=19076824&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pgen.1000612-Amela1">57. <span class="element-citation">Amela I, Cedano J, Querol E. Pathogen proteins eliciting antibodies do not share epitopes with host proteins: A bioinformatics approach. <span><span class="ref-journal">PLoS ONE. </span>2007;<span class="ref-vol">2</span>:e512.</span> doi: <a href="http://dx.doi.org/10.1371/journal.pone.0000512" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=External%7CLink%7CURI" target="_blank">10.1371/journal.pone.0000512</a>. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1885212/">PMC free article</a>]</span> [<a href="/pubmed/17551592" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PLoS+ONE&amp;title=Pathogen+proteins+eliciting+antibodies+do+not+share+epitopes+with+host+proteins:+A+bioinformatics+approach.&amp;author=I+Amela&amp;author=J+Cedano&amp;author=E+Querol&amp;volume=2&amp;publication_year=2007&amp;pages=e512&amp;pmid=17551592&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pgen.1000612-Kanduc1">58. <span class="element-citation">Kanduc D, Stufano A, Lucchese G, Kusalik A. Massive peptide sharing between viral and human proteomes. <span><span class="ref-journal">Peptides. </span>2008;<span class="ref-vol">29</span>:1755\xe2\x80\x931766.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7115663/">PMC free article</a>]</span> [<a href="/pubmed/18582510" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Peptides&amp;title=Massive+peptide+sharing+between+viral+and+human+proteomes.&amp;author=D+Kanduc&amp;author=A+Stufano&amp;author=G+Lucchese&amp;author=A+Kusalik&amp;volume=29&amp;publication_year=2008&amp;pages=1755-1766&amp;pmid=18582510&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pgen.1000612-Kanduc2">59. <span class="element-citation">Kanduc D, Lucchese A, Mittelman A. Non-redundant peptidomes from DAPs: Towards &#x0201c;the vaccine&#x0201d;? <span><span class="ref-journal">Autoimmun Rev. </span>2007;<span class="ref-vol">6</span>:290\xe2\x80\x93294.</span> [<a href="/pubmed/17412300" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Autoimmun+Rev&amp;title=Non-redundant+peptidomes+from+DAPs:+Towards+&#x0201c;the+vaccine&#x0201d;?&amp;author=D+Kanduc&amp;author=A+Lucchese&amp;author=A+Mittelman&amp;volume=6&amp;publication_year=2007&amp;pages=290-294&amp;pmid=17412300&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pgen.1000612-Wraith1">60. <span class="element-citation">Wraith DC, Goldman M, Lambert PH. Vaccination and autoimmune disease: What is the evidence? <span><span class="ref-journal">Lancet. </span>2003;<span class="ref-vol">362</span>:1659\xe2\x80\x931666.</span> [<a href="/pubmed/14630450" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Vaccination+and+autoimmune+disease:+What+is+the+evidence?&amp;author=DC+Wraith&amp;author=M+Goldman&amp;author=PH+Lambert&amp;volume=362&amp;publication_year=2003&amp;pages=1659-1666&amp;pmid=14630450&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pgen.1000612-Gross1">61. <span class="element-citation">Gross DM, Forsthuber T, Tary-Lehmann M, Etling C, Ito K, et al.  Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritis. <span><span class="ref-journal">Science. </span>1998;<span class="ref-vol">281</span>:703\xe2\x80\x93706.</span> [<a href="/pubmed/9685265" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=Identification+of+LFA-1+as+a+candidate+autoantigen+in+treatment-resistant+Lyme+arthritis.&amp;author=DM+Gross&amp;author=T+Forsthuber&amp;author=M+Tary-Lehmann&amp;author=C+Etling&amp;author=K+Ito&amp;volume=281&amp;publication_year=1998&amp;pages=703-706&amp;pmid=9685265&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pgen.1000612-Willett1">62. <span class="element-citation">Willett TA, Meyer AL, Brown EL, Huber BT. An effective second-generation outer surface protein A-derived Lyme vaccine that eliminates a potentially autoreactive T cell epitope. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2004;<span class="ref-vol">101</span>:1303\xe2\x80\x931308.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC337048/">PMC free article</a>]</span> [<a href="/pubmed/14742868" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+U+S+A&amp;title=An+effective+second-generation+outer+surface+protein+A-derived+Lyme+vaccine+that+eliminates+a+potentially+autoreactive+T+cell+epitope.&amp;author=TA+Willett&amp;author=AL+Meyer&amp;author=EL+Brown&amp;author=BT+Huber&amp;volume=101&amp;publication_year=2004&amp;pages=1303-1308&amp;pmid=14742868&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pgen.1000612-Kellam1">63. <span class="element-citation">Kellam P. Attacking pathogens through their hosts. <span><span class="ref-journal">Genome Biol. </span>2006;<span class="ref-vol">7</span>:201.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1431708/">PMC free article</a>]</span> [<a href="/pubmed/16515720" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Genome+Biol&amp;title=Attacking+pathogens+through+their+hosts.&amp;author=P+Kellam&amp;volume=7&amp;publication_year=2006&amp;pages=201&amp;pmid=16515720&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pgen.1000612-Andeweg1">64. <span class="element-citation">Andeweg AC, Haagmans BL, Osterhaus AD. Virogenomics: the virus-host interaction revisited. <span><span class="ref-journal">Curr Opin Microbiol. </span>2008;<span class="ref-vol">11</span>:461\xe2\x80\x93466.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7108363/">PMC free article</a>]</span> [<a href="/pubmed/18822388" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Curr+Opin+Microbiol&amp;title=Virogenomics:+the+virus-host+interaction+revisited.&amp;author=AC+Andeweg&amp;author=BL+Haagmans&amp;author=AD+Osterhaus&amp;volume=11&amp;publication_year=2008&amp;pages=461-466&amp;pmid=18822388&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pgen.1000612-delReal1">65. <span class="element-citation">del Real G, Jimenez-Baranda S, Mira E, Lacalle RA, Lucas P, et al.  Statins inhibit HIV-1 infection by down-regulating Rho activity. <span><span class="ref-journal">J Exp Med. </span>2004;<span class="ref-vol">200</span>:541\xe2\x80\x93547.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2211926/">PMC free article</a>]</span> [<a href="/pubmed/15314078" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Exp+Med&amp;title=Statins+inhibit+HIV-1+infection+by+down-regulating+Rho+activity.&amp;author=G+del+Real&amp;author=S+Jimenez-Baranda&amp;author=E+Mira&amp;author=RA+Lacalle&amp;author=P+Lucas&amp;volume=200&amp;publication_year=2004&amp;pages=541-547&amp;pmid=15314078&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pgen.1000612-deLang1">66. <span class="element-citation">de Lang A, Baas T, Teal T, Leijten LM, Rain B, et al.  Functional genomics highlights differential induction of antiviral pathways in the lungs of SARS-CoV-infected macaques. <span><span class="ref-journal">PLoS Pathog. </span>2007;<span class="ref-vol">3</span>:e112.</span> doi: <a href="http://dx.doi.org/10.1371/journal.ppat.0030112" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=External%7CLink%7CURI" target="_blank">10.1371/journal.ppat.0030112</a>. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1941749/">PMC free article</a>]</span> [<a href="/pubmed/17696609" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PLoS+Pathog&amp;title=Functional+genomics+highlights+differential+induction+of+antiviral+pathways+in+the+lungs+of+SARS-CoV-infected+macaques.&amp;author=A+de+Lang&amp;author=T+Baas&amp;author=T+Teal&amp;author=LM+Leijten&amp;author=B+Rain&amp;volume=3&amp;publication_year=2007&amp;pages=e112&amp;pmid=17696609&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pgen.1000612-International1">67. <span class="element-citation">International HapMap Consortium. A second generation human haplotype map of over 3.1 million SNPs. <span><span class="ref-journal">Nature. </span>2007;<span class="ref-vol">449</span>:851\xe2\x80\x93861.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2689609/">PMC free article</a>]</span> [<a href="/pubmed/17943122" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=A+second+generation+human+haplotype+map+of+over+3.1+million+SNPs.&amp;volume=449&amp;publication_year=2007&amp;pages=851-861&amp;pmid=17943122&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pgen.1000612-Poland1">68. <span class="element-citation">Poland GA, Ovsyannikova IG, Jacobson RM. Application of pharmacogenomics to vaccines. <span><span class="ref-journal">Pharmacogenomics. </span>2009;<span class="ref-vol">10</span>:837\xe2\x80\x93852.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2722448/">PMC free article</a>]</span> [<a href="/pubmed/19450131" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Pharmacogenomics&amp;title=Application+of+pharmacogenomics+to+vaccines.&amp;author=GA+Poland&amp;author=IG+Ovsyannikova&amp;author=RM+Jacobson&amp;volume=10&amp;publication_year=2009&amp;pages=837-852&amp;pmid=19450131&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pgen.1000612-Ovsyannikova1">69. <span class="element-citation">Ovsyannikova IG, Jacobson RM, Dhiman N, Vierkant RA, Pankratz VS, et al.  Human leukocyte antigen and cytokine receptor gene polymorphisms associated with heterogeneous immune responses to mumps viral vaccine. <span><span class="ref-journal">Pediatrics. </span>2008;<span class="ref-vol">121</span>:e1091\xe2\x80\x931099.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2668976/">PMC free article</a>]</span> [<a href="/pubmed/18450852" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Pediatrics&amp;title=Human+leukocyte+antigen+and+cytokine+receptor+gene+polymorphisms+associated+with+heterogeneous+immune+responses+to+mumps+viral+vaccine.&amp;author=IG+Ovsyannikova&amp;author=RM+Jacobson&amp;author=N+Dhiman&amp;author=RA+Vierkant&amp;author=VS+Pankratz&amp;volume=121&amp;publication_year=2008&amp;pages=e1091-1099&amp;pmid=18450852&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pgen.1000612-Sim1">70. <span class="element-citation">Sim E, Lack N, Wang CJ, Long H, Westwood I, et al.  Arylamine N-acetyltransferases: Structural and functional implications of polymorphisms. <span><span class="ref-journal">Toxicology. </span>2008;<span class="ref-vol">254</span>:170\xe2\x80\x93183.</span> [<a href="/pubmed/18852012" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Toxicology&amp;title=Arylamine+N-acetyltransferases:+Structural+and+functional+implications+of+polymorphisms.&amp;author=E+Sim&amp;author=N+Lack&amp;author=CJ+Wang&amp;author=H+Long&amp;author=I+Westwood&amp;volume=254&amp;publication_year=2008&amp;pages=170-183&amp;pmid=18852012&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pgen.1000612-Baudhuin1">71. <span class="element-citation">Baudhuin LM, Langman LJ, O\'Kane DJ. Translation of pharmacogenetics into clinically relevant testing modalities. <span><span class="ref-journal">Clin Pharmacol Ther. </span>2007;<span class="ref-vol">82</span>:373\xe2\x80\x93376.</span> [<a href="/pubmed/17851577" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Pharmacol+Ther&amp;title=Translation+of+pharmacogenetics+into+clinically+relevant+testing+modalities.&amp;author=LM+Baudhuin&amp;author=LJ+Langman&amp;author=DJ+O\'Kane&amp;volume=82&amp;publication_year=2007&amp;pages=373-376&amp;pmid=17851577&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pgen.1000612-Telford1">72. <span class="element-citation">Telford JL, Barocchi MA, Margarit I, Rappuoli R, Grandi G. Pili in gram-positive pathogens. <span><span class="ref-journal">Nat Rev Microbiol. </span>2006;<span class="ref-vol">4</span>:509\xe2\x80\x93519.</span> [<a href="/pubmed/16778837" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Rev+Microbiol&amp;title=Pili+in+gram-positive+pathogens.&amp;author=JL+Telford&amp;author=MA+Barocchi&amp;author=I+Margarit&amp;author=R+Rappuoli&amp;author=G+Grandi&amp;volume=4&amp;publication_year=2006&amp;pages=509-519&amp;pmid=16778837&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pgen.1000612-Lauer1">73. <span class="element-citation">Lauer P, Rinaudo CD, Soriani M, Margarit I, Maione D, et al.  Genome analysis reveals pili in Group B Streptococcus. <span><span class="ref-journal">Science. </span>2005;<span class="ref-vol">309</span>:105.</span> [<a href="/pubmed/15994549" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=Genome+analysis+reveals+pili+in+Group+B+Streptococcus.&amp;author=P+Lauer&amp;author=CD+Rinaudo&amp;author=M+Soriani&amp;author=I+Margarit&amp;author=D+Maione&amp;volume=309&amp;publication_year=2005&amp;pages=105&amp;pmid=15994549&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pgen.1000612-Margarit1">74. <span class="element-citation">Margarit I, Rinaudo CD, Galeotti CL, Maione D, Ghezzo C, et al.  Preventing bacterial infections with pilus-based vaccines: The group B streptococcus paradigm. <span><span class="ref-journal">J Infect Dis. </span>2009;<span class="ref-vol">199</span>:108\xe2\x80\x93115.</span> [<a href="/pubmed/19086816" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Infect+Dis&amp;title=Preventing+bacterial+infections+with+pilus-based+vaccines:+The+group+B+streptococcus+paradigm.&amp;author=I+Margarit&amp;author=CD+Rinaudo&amp;author=CL+Galeotti&amp;author=D+Maione&amp;author=C+Ghezzo&amp;volume=199&amp;publication_year=2009&amp;pages=108-115&amp;pmid=19086816&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pgen.1000612-Mora1">75. <span class="element-citation">Mora M, Bensi G, Capo S, Falugi F, Zingaretti C, et al.  Group A Streptococcus produce pilus-like structures containing protective antigens and Lancefield T antigens. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2005;<span class="ref-vol">102</span>:15641\xe2\x80\x9315646.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1253647/">PMC free article</a>]</span> [<a href="/pubmed/16223875" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+U+S+A&amp;title=Group+A+Streptococcus+produce+pilus-like+structures+containing+protective+antigens+and+Lancefield+T+antigens.&amp;author=M+Mora&amp;author=G+Bensi&amp;author=S+Capo&amp;author=F+Falugi&amp;author=C+Zingaretti&amp;volume=102&amp;publication_year=2005&amp;pages=15641-15646&amp;pmid=16223875&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pgen.1000612-Falugi1">76. <span class="element-citation">Falugi F, Zingaretti C, Pinto V, Mariani M, Amodeo L, et al.  Sequence variation in Group A Streptococcus pili and association of pilus backbone types with Lancefield T serotypes. <span><span class="ref-journal">J Infect Dis. </span>2008;<span class="ref-vol">198</span>:1834\xe2\x80\x931841.</span> [<a href="/pubmed/18928376" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Infect+Dis&amp;title=Sequence+variation+in+Group+A+Streptococcus+pili+and+association+of+pilus+backbone+types+with+Lancefield+T+serotypes.&amp;author=F+Falugi&amp;author=C+Zingaretti&amp;author=V+Pinto&amp;author=M+Mariani&amp;author=L+Amodeo&amp;volume=198&amp;publication_year=2008&amp;pages=1834-1841&amp;pmid=18928376&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pgen.1000612-Barocchi1">77. <span class="element-citation">Barocchi MA, Ries J, Zogaj X, Hemsley C, Albiger B, et al.  A pneumococcal pilus influences virulence and host inflammatory responses. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2006;<span class="ref-vol">103</span>:2857\xe2\x80\x932862.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1368962/">PMC free article</a>]</span> [<a href="/pubmed/16481624" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+U+S+A&amp;title=A+pneumococcal+pilus+influences+virulence+and+host+inflammatory+responses.&amp;author=MA+Barocchi&amp;author=J+Ries&amp;author=X+Zogaj&amp;author=C+Hemsley&amp;author=B+Albiger&amp;volume=103&amp;publication_year=2006&amp;pages=2857-2862&amp;pmid=16481624&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pgen.1000612-Bagnoli1">78. <span class="element-citation">Bagnoli F, Moschioni M, Donati C, Dimitrovska V, Ferlenghi I, et al.  A second pilus type in <em>Streptococcus pneumoniae</em> is prevalent in emerging serotypes and mediates adhesion to host cells. <span><span class="ref-journal">J Bacteriol. </span>2008;<span class="ref-vol">190</span>:5480\xe2\x80\x935492.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2493256/">PMC free article</a>]</span> [<a href="/pubmed/18515415" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Bacteriol&amp;title=A+second+pilus+type+in+Streptococcus+pneumoniae+is+prevalent+in+emerging+serotypes+and+mediates+adhesion+to+host+cells.&amp;author=F+Bagnoli&amp;author=M+Moschioni&amp;author=C+Donati&amp;author=V+Dimitrovska&amp;author=I+Ferlenghi&amp;volume=190&amp;publication_year=2008&amp;pages=5480-5492&amp;pmid=18515415&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pgen.1000612-Gianfaldoni1">79. <span class="element-citation">Gianfaldoni C, Censini S, Hilleringmann M, Moschioni M, Facciotti C, et al.  \n<em>Streptococcus pneumoniae</em> pilus subunits protect mice against lethal challenge. <span><span class="ref-journal">Infect Immun. </span>2007;<span class="ref-vol">75</span>:1059\xe2\x80\x931062.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1828493/">PMC free article</a>]</span> [<a href="/pubmed/17145945" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Infect+Immun&amp;title=&#10;Streptococcus+pneumoniae+pilus+subunits+protect+mice+against+lethal+challenge.&amp;author=C+Gianfaldoni&amp;author=S+Censini&amp;author=M+Hilleringmann&amp;author=M+Moschioni&amp;author=C+Facciotti&amp;volume=75&amp;publication_year=2007&amp;pages=1059-1062&amp;pmid=17145945&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pgen.1000612-Granoff1">80. <span class="element-citation">Granoff DM, Welsch JA, Ram S. Binding of complement factor H (fH) to <em>Neisseria meningitidis</em> is specific for human fH and inhibits complement activation by rat and rabbit sera. <span><span class="ref-journal">Infect Immun. </span>2009;<span class="ref-vol">77</span>:764\xe2\x80\x93769.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2632036/">PMC free article</a>]</span> [<a href="/pubmed/19047406" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Infect+Immun&amp;title=Binding+of+complement+factor+H+(fH)+to+Neisseria+meningitidis+is+specific+for+human+fH+and+inhibits+complement+activation+by+rat+and+rabbit+sera.&amp;author=DM+Granoff&amp;author=JA+Welsch&amp;author=S+Ram&amp;volume=77&amp;publication_year=2009&amp;pages=764-769&amp;pmid=19047406&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pgen.1000612-McNeil1">81. <span class="element-citation">McNeil LK, Murphy E, Zhao XJ, Guttmann S, Harris S, et al.  Detection of LP2086 on the cell surface of <em>Neisseria meningitidis</em> and its accessibility in the presence of serogroup B capsular polysaccharide. <span><span class="ref-journal">Vaccine. </span>2009;<span class="ref-vol">27</span>:3417\xe2\x80\x933421.</span> [<a href="/pubmed/19200847" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Vaccine&amp;title=Detection+of+LP2086+on+the+cell+surface+of+Neisseria+meningitidis+and+its+accessibility+in+the+presence+of+serogroup+B+capsular+polysaccharide.&amp;author=LK+McNeil&amp;author=E+Murphy&amp;author=XJ+Zhao&amp;author=S+Guttmann&amp;author=S+Harris&amp;volume=27&amp;publication_year=2009&amp;pages=3417-3421&amp;pmid=19200847&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pgen.1000612-Koeberling1">82. <span class="element-citation">Koeberling O, Seubert A, Granoff DM. Bactericidal antibody responses elicited by a meningococcal outer membrane vesicle vaccine with overexpressed factor H-binding protein and genetically attenuated endotoxin. <span><span class="ref-journal">J Infect Dis. </span>2008;<span class="ref-vol">198</span>:262\xe2\x80\x93270.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3755350/">PMC free article</a>]</span> [<a href="/pubmed/18505380" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Infect+Dis&amp;title=Bactericidal+antibody+responses+elicited+by+a+meningococcal+outer+membrane+vesicle+vaccine+with+overexpressed+factor+H-binding+protein+and+genetically+attenuated+endotoxin.&amp;author=O+Koeberling&amp;author=A+Seubert&amp;author=DM+Granoff&amp;volume=198&amp;publication_year=2008&amp;pages=262-270&amp;pmid=18505380&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pgen.1000612-Madico1">83. <span class="element-citation">Madico G, Welsch JA, Lewis LA, McNaughton A, Perlman DH, et al.  The meningococcal vaccine candidate GNA1870 binds the complement regulatory protein factor H and enhances serum resistance. <span><span class="ref-journal">J Immunol. </span>2006;<span class="ref-vol">177</span>:501\xe2\x80\x93510.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2248442/">PMC free article</a>]</span> [<a href="/pubmed/16785547" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Immunol&amp;title=The+meningococcal+vaccine+candidate+GNA1870+binds+the+complement+regulatory+protein+factor+H+and+enhances+serum+resistance.&amp;author=G+Madico&amp;author=JA+Welsch&amp;author=LA+Lewis&amp;author=A+McNaughton&amp;author=DH+Perlman&amp;volume=177&amp;publication_year=2006&amp;pages=501-510&amp;pmid=16785547&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pgen.1000612-Masignani2">84. <span class="element-citation">Masignani V, Comanducci M, Giuliani MM, Bambini S, Adu-Bobie J, et al.  Vaccination against <em>Neisseria meningitidis</em> using three variants of the lipoprotein GNA1870. <span><span class="ref-journal">J Exp Med. </span>2003;<span class="ref-vol">197</span>:789\xe2\x80\x93799.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2193853/">PMC free article</a>]</span> [<a href="/pubmed/12642606" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Exp+Med&amp;title=Vaccination+against+Neisseria+meningitidis+using+three+variants+of+the+lipoprotein+GNA1870.&amp;author=V+Masignani&amp;author=M+Comanducci&amp;author=MM+Giuliani&amp;author=S+Bambini&amp;author=J+Adu-Bobie&amp;volume=197&amp;publication_year=2003&amp;pages=789-799&amp;pmid=12642606&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pgen.1000612-Welsch1">85. <span class="element-citation">Welsch JA, Ram S, Koeberling O, Granoff DM. Complement-dependent synergistic bactericidal activity of antibodies against factor H-binding protein, a sparsely distributed meningococcal vaccine antigen. <span><span class="ref-journal">J Infect Dis. </span>2008;<span class="ref-vol">197</span>:1053\xe2\x80\x931061.</span> [<a href="/pubmed/18419542" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Infect+Dis&amp;title=Complement-dependent+synergistic+bactericidal+activity+of+antibodies+against+factor+H-binding+protein,+a+sparsely+distributed+meningococcal+vaccine+antigen.&amp;author=JA+Welsch&amp;author=S+Ram&amp;author=O+Koeberling&amp;author=DM+Granoff&amp;volume=197&amp;publication_year=2008&amp;pages=1053-1061&amp;pmid=18419542&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pgen.1000612-Seib1">86. <span class="element-citation">Seib KL, Serruto D, Oriente F, Delany I, Adu-Bobie J, et al.  Factor H-binding protein is important for meningococcal survival in human whole blood and serum and in the presence of the antimicrobial peptide LL-37. <span><span class="ref-journal">Infect Immun. </span>2009;<span class="ref-vol">77</span>:292\xe2\x80\x93299.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2612274/">PMC free article</a>]</span> [<a href="/pubmed/18852235" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Infect+Immun&amp;title=Factor+H-binding+protein+is+important+for+meningococcal+survival+in+human+whole+blood+and+serum+and+in+the+presence+of+the+antimicrobial+peptide+LL-37.&amp;author=KL+Seib&amp;author=D+Serruto&amp;author=F+Oriente&amp;author=I+Delany&amp;author=J+Adu-Bobie&amp;volume=77&amp;publication_year=2009&amp;pages=292-299&amp;pmid=18852235&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pgen.1000612-Mazurkiewicz1">87. <span class="element-citation">Mazurkiewicz P, Tang CM, Boone C, Holden DW. Signature-tagged mutagenesis: Barcoding mutants for genome-wide screens. <span><span class="ref-journal">Nat Rev Genet. </span>2006;<span class="ref-vol">7</span>:929\xe2\x80\x93939.</span> [<a href="/pubmed/17139324" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Rev+Genet&amp;title=Signature-tagged+mutagenesis:+Barcoding+mutants+for+genome-wide+screens.&amp;author=P+Mazurkiewicz&amp;author=CM+Tang&amp;author=C+Boone&amp;author=DW+Holden&amp;volume=7&amp;publication_year=2006&amp;pages=929-939&amp;pmid=17139324&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2752168&amp;issue-id=181622&amp;journal-id=331&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div></div></div></div><!--post-content--><div class="courtesy-note whole_rhythm small"><hr />Articles from <span class="acknowledgment-journal-title">PLoS Genetics</span> are provided here courtesy of <strong>Public Library of Science</strong></div></div>\n            \n            \n        \n            \n        </div>\n        <!-- Book content -->\n    </div>\n    \n    <div id="rightcolumn" class="four_col col last">\n        <!-- Custom content above discovery portlets -->\n        <div class="col6">\n            \n        </div>\n        \n        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><div class="format-menu"><h2>Formats:</h2><ul><li class="selected">Article</li> | <li><a href="/pmc/articles/PMC2752168/?report=reader">PubReader</a></li> | <li class="epub-link"><a href="/pmc/articles/PMC2752168/epub/">ePub (beta)</a></li> | <li><a href="/pmc/articles/PMC2752168/pdf/pgen.1000612.pdf">PDF (236K)</a></li> | <li><a href="#" data-citationid="PMC2752168" class="citationexporter ctxp">Citation</a></li></ul></div></div><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="share-buttons"><h2>Share</h2><ul><li class="facebook"><a href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2752168%2F"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047626" alt="Share on Facebook" />\n                             Facebook\n                        </a></li><li class="twitter"><a href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2752168%2F&amp;text=The%20Key%20Role%20of%20Genomics%20in%20Modern%20Vaccine%20and%20Drug%20Design%20for%20Emerging%20Infectious%20Diseases"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047627" alt="Share on Twitter" />\n                             Twitter\n                        </a></li><li class="gplus"><a href="https://plus.google.com/share?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2752168%2F"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047628" alt="Share on Google Plus" />\n                             Google+\n                        </a></li></ul></div>\n        \n        <div id="ajax-portlets" data-pmid="19855822" data-aiid="2752168" data-aid="2752168" data-iid="181622" data-domainid="331" data-domain="plosgen" data-accid="PMC2752168" data-md5="1b0315d4ec599f2d45c1d1265a2319c4"></div>\n                \n        <!-- Custom content below discovery portlets -->\n        <div class="col7">\n            \n        </div>\n    </div>\n</div>\n\n<!-- Custom content after all -->\n<div class="col8">\n    \n</div>\n<div class="col9">\n    \n</div>\n\n<script src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>\n<script>\n    (function($){\n        $(\'.skiplink\').each(function(i, item){\n            var href = $($(item).attr(\'href\'));\n            href.attr(\'tabindex\', \'-1\').addClass(\'skiptarget\'); // ensure the target can receive focus\n            $(item).on(\'click\', function(event){\n                event.preventDefault();\n                $.scrollTo(href, 0, {\n                    onAfter: function(){\n                        href.focus();\n                    }\n                });\n            });\n        });\n    })(jQuery);\n</script>\n\n\n\n<div id="body-link-poppers"></div>\n                        </div>\n                        <div class="bottom">\n                            \n                            <div id="NCBIFooter_dynamic">\n    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>\n    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2020-04-17T20:24:13-04:00&amp;Snapshot=%2Fprojects%2FPMC%2FPMCViewer@4.46&amp;Host=ptpmc102&amp;ncbi_phid=8A1BCFE9E9A46CB10000000001000100&amp;ncbi_session=8A1BCFE9E9A48AC1_0256SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2752168%2F&amp;Db=pmc&amp;folderID=132&amp;Ncbi_App=pmc&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>\n    \n</div>\n\n                            <div class="footer" id="footer">\n    \n    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>\n    <div id="external-disclaimer" class="offscreen_noflow">\n        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.\n    </div>    \n    <div id="ncbifooter" class="contact_info">      \n        <div id="footer-contents-right">\n            <div id="nlm_thumb_logo">\n                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>\n            </div>\n            <div id="nih_thumb_logo">\n                <a href="https://www.nih.gov" title="NIH">NIH</a>\n            </div>\n            <div id="hhs_thumb_logo">\n                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>\n            </div>\n            <div id="usagov_thumb_logo">\n                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>\n            </div>         \n        </div>\n        \n        <div id="footer-contents-left">\n            <p class="address vcard">\n                <span class="url">\n                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for\n                        Biotechnology Information</a>,\n                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>\n                <span class="adr">\n                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>\n                    <span class="region">MD</span>, <span class="postal-code">20894</span>\n                    <span class="country-name">USA</span>\n                </span>\n            </p>\n            \n            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>\n        </div>\n    </div>\n    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    \n    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>\n</div>\n                        </div>\n                    </div>\n                    <!--/.page-->\n                </div>\n                <!--/.wrap-->\n            </div><!-- /.twelve_col -->\n        </div>\n        <!-- /.grid -->\n\n        <span class="PAFAppResources"></span>\n        \n        <!-- BESelector tab -->\n        \n        \n        \n        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=pmc&amp;ncbi_pdid=article&amp;ncbi_acc=&amp;ncbi_domain=plosgen&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/articles/PMC2752168/&amp;ncbi_app=pmc" /></noscript>\n        \n        \n        <!-- usually for JS scripts at page bottom -->\n        <!--<component id="PageFixtures" label="styles"></component>-->\n    \n\n<!-- 8A1BCFE9E9A48AC1_0256SID /projects/PMC/PMCViewer@4.46 ptpmc102 v4.1.r585844 Mon, May 06 2019 02:53:16 -->\n\n<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/js/3879255/4121861/3818874/4168176/3821238/4117325/4087685/4072593/4076480/3921943/4105668/4065628.js" snapshot="pmc"></script></body>\n</html>'